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Abstract
College students have an increased risk for cannabis use, trauma exposure, and posttraumatic
stress disorder (PTSD). Cannabis use disorder (CUD) and PTSD comorbidity is high, and given
the negative consequences of the comorbidity (e.g., poor academic outcomes), there is a need to
understand comorbid CUD-PTSD etiology. Two primary etiologic models exist: self-medication
(i.e., PTSD à CUD) and high-risk (i.e., CUD à PTSD) hypotheses. This study 1) examined the
prevalence and predictors of cannabis use and interpersonal trauma (IPT) exposure; 2)
investigated the relationship between cannabis use and IPT; and 3) examined cannabis use, IPT,
and PTSD through mediational self-medication and high-risk hypotheses lenses in a large (n =
9,889) longitudinal study of college students. Aim 1 found the prevalence of lifetime problematic
(i.e., use ≥ 6 times) and experimental (i.e., use 1-5 times) cannabis use was 28.3% and 17.4%,
respectively. Aim 1 results also estimated that the prevalence of lifetime IPT exposure was
35.9%. Aim 2 results supported the self-medication hypothesis, but not the high-risk hypothesis.
Overall model fit from Aim 3 was poor. Nonetheless, Aim 3 results did not support the selfmedication or high-risk hypotheses. Given the poor model fit of Aim 3, results should be
interpreted with caution. However, as a whole, these findings provide preliminary support for the
self-medication hypothesis, indicating that those reporting IPT exposure and probable PTSD may
be at risk for cannabis use. Implications of these findings, in light of study limitations, are
discussed.
Keywords: cannabis, substance use, trauma, interpersonal trauma, posttraumatic stress disorder
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Statement of the Problem
Public support for the legalization of cannabis is increasing (Kilmer & MacCoun, 2017),
which may be contributing to the high prevalence of use. Indeed, cannabis is the currently most
widely used illicit substance in the United States (U.S.) (Substance Abuse and Mental Health
Services Administration, 2016). Cannabis use and cannabis use disorder (CUD) are common in
the general population, and among college students (Hasin et al., 2016; Johnston, O’Malley,
Bachman, Schulenberg, & Miech, 2016). Of concern, cannabis use is higher among college
students than their same-age, non-college peers (Johnston et al., 2016). Most long-term adverse
effects of cannabis use are more likely among heavy or chronic users, but short-term adverse
effects can affect anyone regardless of frequency of use (Hall & Degenhardt, 2009; Kalant,
2004). Functional short-term consequences of cannabis use include neurocognitive impairment
(i.e., problems with psychomotor function, attention, memory, and learning), which can
negatively affect the large number of individuals who use cannabis occasionally or moderately.
Thus, the identification of etiological factors associated with cannabis use and CUD, particularly
among high-risk populations such as college students, are needed to inform prevention and
intervention programming.
Two key potential factors associated with cannabis use that warrant increased study are
trauma exposure and posttraumatic stress disorder (PTSD), both of which are common among
college students (Netto et al., 2013; Read, Ouimette, White, Colder, & Farrow, 2011; Scarpa et
al., 2002; Vrana & Lauterbach, 1994). In addition, college students are also at higher risk for
certain types of traumatic events that have a high likelihood of leading to PTSD, such as
interpersonal trauma (IPT) (Anders, Frazier, & Shallcross, 2012; Anders, Shallcross, & Frazier,
2012; Edwards, Catling, & Parry, 2016). Epidemiological and acute trauma studies suggest that
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trauma exposure and PTSD are associated with cannabis use and CUD and that PTSD and CUD
frequently co-occur (Cougle, Bonn-Miller, Vujanovic, Zvolensky, & Hawkins, 2011; Kevorkian
et al., 2015; Vlahov et al., 2002).
There are numerous phenotypic models posited to explain comorbid PTSD and CUD.
Co-occurrence of these two conditions may begin when a person attempts to self-medicate their
PTSD symptoms (Chilcoat & Breslau, 1998), or CUD could lead to PTSD if the person
experiences trauma caused by their cannabis use (Chilcoat & Breslau, 1998), like a car accident
or physical violence. There is a need for empirical investigation of these models explaining
comorbid PTSD and CUD particularly as public support for the legalization of cannabis is
increasing (Kilmer & MacCoun, 2017), which may further increase cannabis use.
The increasing prevalence of cannabis use and its adverse health effects combined with
an increased risk for trauma exposure among college students makes the intersection of CUD and
PTSD an area in need of future research. Indeed, etiologic models of CUD and PTSD have not
been fully elucidated. Limited epidemiological studies are available on the association between
CUD and PTSD specifically, as most studies have examined the co-occurrence of PTSD and
other substance use disorders such as alcohol use disorder or tobacco use disorder (Debell et al.,
2014; Fu et al., 2007). Even fewer have examined the association between cannabis use and posttrauma phenotypes longitudinally which will allow for testing of direction of causation between
these conditions.
Literature Review
Prevalence of Cannabis Use Phenotypes
Cannabis has been the most commonly used illicit substance in the U.S. for several
decades (Johnston, O'Malley, Bachman, & Schulenberg, 2006; Rouse, Sanderson, & Feldmann,
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2002). According to the U.S. National Survey on Drug Use and Health (NSDUH) 2015 annual
report, the lifetime prevalence of cannabis use was 44% (approximately 117.9 million people)
and cannabis use in the past month increased from 6.2% in 2002 to 8.3% (approximately 22.2
million people) in 2015 among people aged 12 or older (Substance Abuse and Mental Health
Services Administration, 2016). Research suggests that about 10% of those who ever use
cannabis become daily users, and about 20% to 30% become weekly users (Hall & Pacula,
2003). Individuals who use cannabis weekly or more have an increased risk for developing a
substance use disorder (SUD) than experimental users (Swift, Coffey, Carlin, Degenhardt, &
Patton, 2008).
While the majority of cannabis use remains recreational, a notable number of individuals
go on to develop CUD, a disorder characterized by the harmful consequences of repeated
cannabis use, a pattern of compulsive cannabis use, and in some cases physiological dependence
on cannabis (i.e., tolerance and/or symptoms of withdrawal) (American Psychiatric Association,
2013). CUD is only diagnosed when cannabis use becomes persistent and causes significant
academic, occupational or social impairment. CUD in Diagnostic and Statistical Manual of
Mental Disorders (DSM-5) combines the DSM-IV categories of cannabis abuse and dependence
into a single disorder measured on a continuum from mild to severe. In addition to the DSM-IV
abuse and dependence diagnoses being combined into a singular diagnosis for DSM-5 CUD, the
symptom of recurrent legal problems has been removed, and the symptom of craving or a desire
or urge to use cannabis has been added. Given the numerous changes in criteria, comparing
prevalence of CUD to the prior abuse and dependence diagnoses is difficult. For example,
whereas a diagnosis of DSM-IV cannabis abuse previously required only one symptom, mild
cannabis use in DSM-5 requires two to three symptoms from a list of 11. Therefore, it is
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currently more difficult to reach the threshold for DSM-5 CUD than DSM-IV. A study published
using the National Epidemiological Survey on Alcohol and Related Conditions (NESARC) data
in 2011 estimated an 8.9% cumulative probability of developing lifetime cannabis dependence
based on DSM-IV criteria for substance dependence among individuals who reported any history
of cannabis use (Lopez-Quintero et al., 2011). In an epidemiological study estimating the
prevalence of DSM-IV cannabis abuse and dependence among a large nationally representative
sample of U.S. adults, Stinson and colleagues (2006) found the prevalence of lifetime (8.5%) and
12-month (1.5%) CUD (i.e., abuse or dependence). More specifically, the prevalence of 12month (1.1%) and lifetime (7.2%) DSM-IV cannabis abuse surpassed the rates of 12-month
(0.3%) and lifetime (1.3%) cannabis dependence (Stinson et al., 2006).
Multiple lines of evidence support the conclusion that cannabis use is on the rise. One
study analyzed Veteran Administration medical record data and found an increase of about 50%
in CUD with co-occurring SUDs from 2002 to 2009 and an increase of 115% in CUD without
other SUDs during the same time period (Bonn-Miller, Harris, & Trafton, 2012). Using data on
illicit substances involved with fatally injured motor vehicle accidents in U.S. emergency
hospital visits from 2004 to 2011, researchers found a 62% increase in cannabis use (Brady & Li,
2014). Additionally, another study analyzing cannabis metabolites of individuals with the
Fatality Analysis Reporting System from 1999 to 2010 reported a 200% increase in cannabis use
(Drug Abuse Warning Network, 2011). Analyzing data collected from three cross-sectional adult
surveys (e.g., the 1991-1992 National Longitudinal Alcohol Epidemiologic Survey, the 20012002 NESARC, 2012-2013 NESARC–III), Hasin and colleagues (2017) concluded that states
that allow medicinal cannabis use have an increased risk for cannabis use and CUD.
Additionally, rates of cannabis use and CUD are increasing at a significantly greater rate in states
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that allow medicinal cannabis use than in states that do not (Hasin et al., 2017). Given the high
prevalence of cannabis use in the U.S. population, it is critical to examine factors that are related
to use and the transition from use to problematic use (e.g., daily, weekly, or heavy use; CUD) in
order to inform effective prevention and intervention programming.
Sex and Cannabis Use Phenotypes
Generally, extant studies suggest that men are more likely to use cannabis than women,
and the differences tend to be most stark at higher frequency levels. Based on a longitudinal
nationally representative sample of high school graduates in the U.S. from 1975 to 2015, the sex
gap has averaged about 5 to 9 percentage points for 19- to 30-year olds since 1995 (Johnston et
al., 2016). Additionally, daily cannabis use levels were more than twice as high for men than
women (8.1% versus 3.8%) in 2015 (Johnston et al., 2016). The NSDUH found that the
prevalence of past-year cannabis use increased for both men (+4.0%) and women (+2.7%) from
2002 to 2014 (Carliner et al., 2017). Increases were greater for men (+4.4%) than women
(+2.7%) between 2007 and 2014, leading to a widening of the sex gap over time (Carliner et al.,
2017). Both the growing positive public perception and increasing rates of cannabis use likely
play a role in cannabis being the drug with the highest rate of problematic use regardless of sex
in the U.S. (Substance Abuse and Mental Health Services Administration, 2016).
Similar to cannabis use, patterns of CUD mirror those of past-year and daily cannabis use
in terms of sex. Based on results from the 2001-2002 NESARC, the prevalence of lifetime CUD
was higher in men (11%) than women (5%) (Khan et al., 2013). Additionally, men were using at
higher quantities per day compared to women (3.38 versus 2.54 joints per day) and the average
duration of the longest episode of CUD was higher in men compared to women (40.43 versus
31.01 weeks) (Khan et al., 2013). Findings from the 2012-2013 NESARC-III were comparable
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to results from the 2001-2002 NESARC, which suggests that the sex gap is not widening in
terms of CUD as it is with past-year cannabis use (Hasin et al., 2016). Men were 2.2 times more
likely than women to meet DSM-5 criteria for any severity of past 12-month CUD. Additionally,
men were 2.8 times more likely to meet DSM-5 criteria for past 12-month severe CUD than were
women, 1.8 times more likely for moderate CUD, and 2.2 times more likely for mild CUD
(Hasin et al., 2016). Men were 2.1 times more likely than women to meet DSM-5 criteria for
lifetime CUD. Additionally, men were 2.4 times more likely to meet DSM-5 criteria for lifetime
severe CUD than were women, 2.1 time more likely for moderate CUD, and 1.9 times more
likely for mild CUD (Hasin et al., 2016). Collectively, these findings suggest that there may be
sex-specific pathways that influence the initiation of cannabis use and the development of CUD.
Thus, it is important to consider sex-specific patterns of cannabis use and CUD in future
research. Similar to sex, race and ethnicity are other un-modifiable factors that contribute to an
individual’s risk for cannabis use and CUD.
Race, Ethnicity, and Cannabis Use Phenotypes
Generally, research shows that African-American and Hispanic individuals are more
likely to use cannabis than other racial/ethnic groups (Pacek, Malcolm, & Martins, 2012;
Warner, 2016). All racial/ethnic groups saw an increase in cannabis use across the 2001-2002
NESARC and 2012-2013 NESARC-III, but the difference was higher for certain groups (Hasin
et al., 2015). Specifically, significant increases in cannabis use were seen among Caucasian
(4.1% versus 9.4%), African-American (4.7% versus 12.7%), Native American (7.0% versus
17.1%), and Hispanic (3.3% versus 8.4%) individuals (Hasin et al., 2015). Trends in cannabis
use from 1999-2013 among a national sample of U.S. high school students mirror national
prevalence estimates for adults (Johnson et al., 2015). By 2013, four of the seven racial/ethnic
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groups had a prevalence of current cannabis use that exceeded 25%: African-American (29%),
Hispanic (28%), American-Indian (36%) and Multi-Racial individuals (29%), whereas the
prevalence of use was lower among Caucasian individuals (22%) and Asian-American
Individuals (11%) (Johnson et al., 2015). Similar to cannabis use, the rates of past 12-month
DSM-IV CUDs increased among African-American (1.8% versus 4.6%) and Hispanic (1.2%
versus 2.8%) individuals (Hasin et al., 2015). Higher levels of cannabis use among AfricanAmerican, Hispanic, and American-Indian individuals deserve public health attention because
these groups are more likely than Caucasian individuals to experience negative consequences of
cannabis use, including CUD and negative psychosocial outcomes (Edwards, Bunting, & Garcia,
2015). Thus, it is important to consider both racial- and ethnic-specific patterns of cannabis use
and CUD in future research.
Age and Cannabis Use Phenotypes
Generally, research shows that individuals between the ages of 18- and 25-years old are
more likely to use cannabis compared to older adults (Suerken et al., 2014). Based on results
from the 2012-2013 NESARC, the prevalence of past-year cannabis use was highest among 18to 29-year olds (21%) and decreased with age (30- to 34-year olds (10%), 45- to 64-year olds
(6%), 65-year olds and older (1%) (Hasin et al., 2015). Similarly, according to the 2015
NSDUH, cannabis use is most prevalent among young individuals ages 18- to 25-years old, with
an estimated 19.8% using in the past month (Center for Behavioral Health Statistics and Quality,
2014). Not surprisingly, estimated prevalence of CUD among age groups follows a similar
pattern as cannabis use. Based on results from the 2012-2013 NESARC, the prevalence of DSMIV past-year CUDs (e.g., abuse or dependence) was highest among 18- to 29-year olds (7.5%)
and decreased with age (30- to 34-year olds (2.9%), 45- to 64-year olds (1.3%), 65-year olds and
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older (0.3%)) (Hasin et al., 2015). Despite DSM-5 no longer distinguishing between DSM-IV
cannabis abuse and dependence, the list of DSM-5 CUD symptoms are nearly identical to DSMIV cannabis abuse and dependence. Therefore, rates of CUD remain relatively similar across the
two diagnostic rubrics. According to the 2012-2013 NESARC adjusted for DSM-5 criteria, 6.9%
and 11% of 18- to 29-year olds, 2.5% and 7.4% of 30- to 44-year olds, 0.8% and 3.7% of 45-year
olds and older met DSM-5 criteria for 12-month CUDs (mild, moderate, or severe) and lifetime
CUD, respectively (Hasin et al., 2016). In summary, recent epidemiologic studies show that
young adults were found to be at highest risk for cannabis use and CUD when examined by age,
and also suggest that the average age of onset is around the same timeframe.
Based on two epidemiological studies (Hasin et al., 2016; Stinson et al., 2006), the
average age of onset for CUD appears to be during young adulthood. The average ages of onset
for DSM-IV cannabis abuse and dependence were 19.3-years old and 19.0-years old,
respectively (Stinson et al., 2006). Based on the 2012-2013 NESARC, the average age at onset
of DSM-5 CUD was 21.7 years-old (Hasin et al., 2016). Thus, the estimated average age of onset
of CUDs overlaps with an important developmental period for most individuals—college.
College students have become an important population to study in order to prevent public health
problems, especially drug use, because of its size (estimated 20.4 million students in American
colleges and universities in Fall 2017) and critical age range (average age range of 18- to 24years old) (National Center for Education Statistics & US Department of Education, 2016).
Approximately one-third of young adults between the ages of 18- and 24-years old are enrolled
in post-secondary education (National Center for Education Statistics & US Department of
Education, 2016). The college years represent a particularly important developmental phase.
Most students are away from home for the first time without parental supervision and are trying
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to adjust, socialize, and fit in. In addition to adjusting to being away from home, students are
attending parties with alcohol and other illegal substances, which makes college a potentially
dangerous period. Therefore, college students are more vulnerable to new, sometimes prohibited
or illicit, experiences (Leibsohn, 1994; Walsh, 1992). A number of epidemiologic studies suggest
that the prevalence of CUD is highest among young adults (Center for Behavioral Health
Statistics and Quality, 2014; Hasin et al., 2016; Hasin et al., 2015; Suerken et al., 2014), and also
suggest that the age of onset of CUD is in young adulthood (Hasin et al., 2016). Thus, it is
critical to consider age-specific patterns of cannabis use and CUD in future research as well as
study cannabis use and CUD among college students and how changes in their environment
influence use.
Cannabis Use Phenotypes among College Students. Postsecondary education has
become all but required for a well-paying career in today’s economy and, as a result, college
enrollment rates are skyrocketing. Between 2000 and 2015, the 18- to 24-year-old population
rose from approximately 27.3 million to nearly 31.2 million (National Center for Education
Statistics & US Department of Education, 2016). Likewise, the estimated number of 18- to 24year olds enrolled in college also rose from approximately 15.3 million to nearly 19.9 million
between 2000 and 2015 (National Center for Education Statistics & US Department of
Education, 2016). In a sample of 3,146 college students from 11 colleges and universities in
North Carolina and Virginia, nearly 30% of students reported using cannabis prior to enrolling in
college (Suerken et al., 2014). Suerken and colleagues (2014) also found that 8.5% of college
students who did not use cannabis prior to starting college initiated use during freshman year. As
of 2016, the Monitoring the Future survey results revealed that 1 in 5 college students will
become first-time users of cannabis during their time in college (Johnston et al., 2016). Although
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students who attend college are less likely to use cannabis prior to graduating from high school
than their peers who do not attend college, the prevalence of cannabis use among young adults
attending college is increasing at a higher rate than the prevalence of cannabis use among their
counterparts who do not attend college (Johnston et al., 2016; White, Labouvie, &
Papadaratsakis, 2005). Past-year cannabis use was 51% higher among college students than their
same-age, non-college peers in 2015, 41% in 2014, and 31% in 2013 (Johnston et al., 2016). The
National Survey Results on Drug Use from 1975-2015 reported that perceived availability of
cannabis is higher among 12th graders through 27- to 30-year-olds versus 35- to 55-year-olds
(81-87% versus 69-80%), which could play a role in why cannabis is currently the most
commonly used illicit drug among college students (Blavos et al., 2017; Johnston et al., 2016;
Suerken et al., 2014).
Trends in cannabis use among college students mirror trends in the general population.
The National Survey Results on Drug Use from 1975-2015 also found that cannabis use is higher
among college males than females (40% versus 33%) and college males are three times as likely
to report daily cannabis use compared to females (8.7% versus 3.9%) (Johnston et al., 2016).
Among a random sample of first-year college students from two large public universities, 65.1%
of students who reported cannabis use in the past month also reported alcohol use during that
time period and 23.2% of males and 8.5% of females reported using both substances on the same
day (Whitehill, Rivara, & Moreno, 2014). Concurrent use of cannabis and alcohol is one of the
most common forms of polydrug mix among college students and one of the best predictors of
both substances use is peer use (Windle, Haardorfer, Lloyd, Foster, & Berg, 2017). Since
cannabis use phenotypes are often comorbid with other substance use phenotypes (e.g., nicotine
and alcohol; i.e., polysubstance use) those are key variables to control for in future cannabis use
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research. The strong association between peer use and cannabis use among college students may
be due to greater personal autonomy, different living circumstances, a new and larger
socialization network, increasing legalization in some states, and perceived easier access to
substances (Windle & Zucker, 2010). Thus, it is important to examine potentially modifiable
variables (i.e., other substance use, peer substance use, social network, coping strategies)
associated with increased risk for cannabis use. College may be a period of increased risk for
exposure to problematic cannabis use, but it is also a time of increased risk to trauma exposure,
which both can contribute to the development of cannabis use phenotypes among college
students.
Summary: Correlates of Cannabis Use Phenotypes
In summary, cannabis is the most commonly used illicit drug (Johnston et al., 2006;
Rouse et al., 2002). Those in the general population between the ages of 18- and 29-years old
have been shown to be at high risk for this type of substance misuse, with usage rates of 21%
(Hasin et al., 2015). Race and ethnicity, sex, and year-in-school have often been cited as
covariates in cannabis use and CUD literature. However, there continues to be a lack of
consensus on rates and motivations based on these demographics. Thus, it is important to
consider age-, sex-, racial-, and ethnic-specific patterns of cannabis use and CUD in future
cannabis research in order to give clarity to these discrepancies. It is also important to control for
other substance use phenotypes (e.g., nicotine and alcohol) that are commonly used with
cannabis in further cannabis research. In addition to age, sex, race, and ethnicity as established
risk factors for cannabis use, there are also associations between trauma-related factors (i.e.,
trauma exposure and PTSD) and cannabis phenotypes (i.e., cannabis use and CUD).
Prevalence and Correlates of Trauma Exposure and PTSD
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According to the American Psychiatric Association’s (APA) DSM-5 (2013), a traumatic
event is defined as “exposure to actual or threatened death, serious injury, or sexual violence,”
which includes, but is not limited to, sexual abuse, physical abuse, domestic violence,
community and school violence, suicides, and other traumatic losses. Trauma exposure is
universally common among all populations. Twenty-four countries across six continents assessed
trauma exposure with a list of 29 types of traumatic events among a sample of 68,894 adults and
over 70% of respondents reported exposure to at least one traumatic event and 30.5% reported
exposure to four or more traumatic events (Benjet et al., 2016). The U.S. had the third highest
prevalence of trauma exposure (82.7%) of all countries included in the study (Benjet et al.,
2016). Consistently, in a representative sample of U.S. adults, most respondents (89.7%)
reported exposure to at least one DSM-5 PTSD Criterion A traumatic event (Kilpatrick et al.,
2013).
Sociodemographic predictors of trauma exposure include sex, race, ethnicity, and age.
Women are more likely than men to be exposed to intimate partner or sexual violence, but men
are more likely than women to experience all other types of traumatic events such as
interpersonal violence (i.e., human-perpetrated violence) or being mugged with a weapon (Benjet
et al., 2016). Similar to sex, racial/ethnic group differences in risk for exposure to traumatic
events has been shown to vary by type of event. Based on a large, representative sample of U.S.
adults, Roberts and colleagues (2011) found that Caucasian individuals were more likely than
other racial/ethnic groups to be exposed to any traumatic event, but African-American and
Hispanic individuals were more likely than Caucasian individuals to be exposed to childhood
trauma and witnessing domestic violence, and African-American, Hispanic, and Asian-American
individuals had a higher risk of war-related trauma exposure than Caucasian individuals.
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Regarding cohort effects, individuals below the age of 65-years old are more likely to experience
interpersonal violence, sexual violence, accidents, injuries, unexpected death of a loved one, and
being mugged, but this increased risk decreases with age (Benjet et al., 2016). Being a college
student was specifically associated with an increased risk for most types of trauma exposure
unrelated to collective violence, having a life-threatening illness, and having a child with a
serious illness suggesting something unique about the developmental period of college (Benjet et
al., 2016).
Exposure to a traumatic event is a criterion for a diagnosis of PTSD. PTSD is a disorder
characterized by the following primary symptom areas: exposure to a traumatic event, intrusion
or re-experiencing (i.e., recurrent recollections of the event), fear or avoidance behaviors,
changes in mood and cognition (i.e., negative alterations in emotions or thoughts), arousal and
hyper-reactivity (i.e., agitation, state of constant wakefulness and alertness) (American
Psychiatric Association, 2013). PTSD is only diagnosed when the symptoms last more than a
month, seriously affect an individual’s ability to function, and are not due to substance use,
medical illness, or anything except the event itself. According to a systematic review of 35
studies investigating PTSD prevalence and trajectories in trauma exposed populations, an
estimated 25.4% of those exposed to a traumatic event go on to meet DSM-5 criteria for PTSD
one month post-trauma (Santiago et al., 2013). PTSD prevalence rates decrease to 18.8% three
months post-trauma and remain steady at twelve months post-trauma (17.7%) (Santiago et al.,
2013). The National Comorbidity Survey – Replication (NCS-R) estimated the prevalence rate of
lifetime PTSD based on the DSM-IV diagnostic criteria to be about 6.8% among a nationally
representative sample of U.S. adults (Kessler, Berglund, et al., 2005). The National
Epidemiologic Survey on Alcohol and Related Conditions documented similar estimates of
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DSM-IV lifetime PTSD (6.4%) among a representative sample of U.S. adults (Pietrzak,
Goldstein, Southwick, & Grant, 2011). PTSD in DSM-5 differs significantly from DSM-IV. The
stressor criterion is more explicit with regard to what classifies as a traumatic event. Also, the
subjective reaction of needing to feel intense fear, helplessness, or horror during the traumatic
event has been removed. The three major symptom clusters in DSM-IV (e.g., reexperiencing,
avoidance/numbing, and arousal) are now four symptom clusters in DSM-5. The DSM-IV
avoidance/numbing cluster is divided into two distinct clusters in the DSM-5: avoidance and
negative alterations in cognitions and mood. Negative alterations in cognitions and mood
retained most of the DSM-IV numbing symptoms, but also includes new symptoms, such as
persistent negative emotional states. Lastly, alterations in arousal and hyper-reactivity retains
most of the DSM-IV arousal symptoms, but also includes irritable or aggressive behavior and
reckless or self-destructive behavior. Despite these major revisions to what qualifies for a
diagnosis of PTSD, the prevalence rates remain relatively similar across the DSM-IV and DSM5. More recently, results from the National Stressful Events Survey documented similar
estimates of DSM-IV lifetime PTSD (10.6%) and DSM-5 lifetime PTSD (9.4%), which sampled
a demographically and geographically representative group of U.S. adults (Kilpatrick et al.,
2013).
Many factors play a part in whether an individual will develop PTSD after experiencing a
traumatic event. In a meta-analysis across 77 studies examining risk factors for PTSD in traumaexposed adults, Brewin and colleagues (2000) found pre-trauma (e.g., sex, race, low
socioeconomic status), peri-trauma (e.g., trauma severity), and post-trauma (e.g., low social
support, subsequent life stress) factors that were associated with a greater likelihood of
developing PTSD. Although women are less likely than men to be exposed to a traumatic event,
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women have a two to three times higher risk of developing PTSD compared to men (Olff, 2017).
The lifetime prevalence of PTSD ranges from 10–12% in women and 5–6% in men (Olff, 2017).
Racial/ethnic differences in PTSD have been investigated and Roberts and colleagues (2011)
found that the lifetime prevalence of PTSD was highest among African-American individuals
(8.7%), intermediate among Caucasian and Hispanic individuals (7.4% and 7.0%), and lowest
among Asian-American Individuals (4.0%). Regarding age as a pre-trauma vulnerability factor
for PTSD, the NCS-R found that individuals aged 18- to 29-years old had the highest odds of a
lifetime risk for PTSD compared to 30- to 44-year olds and 45- to 59-year olds (Kessler,
Berglund, et al., 2005). College students are in that critical age range for an increased risk for
PTSD and constitute a sizeable cohort of the U.S. population. These pre-trauma characteristic
differences are attributed to a variety of cultural, socioeconomic, and cohort phenomena.
Psychosocial factors, in addition to demographic variables, contribute to PTSD risk. A
meta-analysis across 68 studies examining predictors of PTSD and symptoms in adults found
that risk factors for developing PTSD besides low social support had a stronger effect if the
index trauma was noncombat interpersonal violence (Ozer, Best, Lipsey, & Weiss, 2003).
Similarly, Frans and colleagues (2005) examined the lifetime prevalence of traumatic
experiences and PTSD and found that the highest risk for developing PTSD was associated with
IPT (i.e., sexual and physical assault), robbery, and multiple trauma experiences. Recently,
Kilpatrick and colleagues (2013) also found that the prevalence of PTSD was highest among
victims of IPT and combat. Consistent evidence supports IPT being more likely to lead to PTSD
than accidental trauma. Ozer and colleagues (2003) also found that low perceived social support
following a traumatic event was associated with greater development of PTSD. According to
Brewin and colleagues (2000), lack of social support and more subsequent life stress were two of
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the three peri- and post-trauma factors that convey the strongest risk of PTSD. Given the
knowledge on pre- peri- and post-trauma risk factors, it is important to investigate trauma
exposure and PTSD in high risk subpopulations (i.e., college students) in order to better
understand the negative effects both acutely and in the longer-term.
Trauma Exposure and PTSD among College Students. Trauma exposure is common
among young adults, and exposure in young adults in a college environment is of particular
concern. Estimates of the prevalence of exposure to traumatic events among college students
have been as high as 84% (Scarpa et al., 2002; Vrana & Lauterbach, 1994). More recently,
preliminary results from Spit for Science, an ongoing representative study of college students
used for the current study, found a similarly high prevalence rate of exposure to traumatic events
(82%) (Overstreet, Berenz, Kendler, Dick, & Amstadter, 2017). Additionally, 39% of college
students reported a lifetime prevalence of experiencing an interpersonal traumatic event, which is
more likely to lead to PTSD than accidental trauma. Using a more conservative definition of a
traumatic event, Read and colleagues (2011) found the prevalence of DSM-IV criterion A trauma
exposure among newly matriculated college students to be slightly lower (66%) than exposure to
traumatic events. More specifically, 23% reported exposure to one traumatic event, 20% reported
two events, and 25% reported three or more events. In a sample of college students, 67% of
participants reported experiencing at least one traumatic event based on DSM-5 PTSD’s criteria
and 59% of participants met criteria for DSM-5 PTSD (Elhai et al., 2012). Notably, rates of
occurrence of trauma exposure have been shown to peak sharply between ages 16- to 20-years
old, which overlaps with the ages of the average college population (Breslau et al., 1998).
Therefore, college students are at an increased risk for trauma exposure and PTSD than the
general population across the lifespan.
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Lifetime estimates of DSM-IV and DSM-5 PTSD in the general population are as high as
10% (Kilpatrick et al., 2013). Similar to how college students have an increased risk for trauma
exposure compared to other age groups, they also have an increased risk for developing PTSD. A
limited number of recent studies have examined the prevalence of trauma exposure and PTSD in
college students, estimating rates of PTSD to be in the range of 8%–15% (Frazier et al., 2009;
Netto et al., 2013; Read et al., 2011; Smyth, Hockemeyer, Heron, Wonderlich, & Pennebaker,
2008; Watson & Haynes, 2007). Studies suggest that college students are at an increased risk for
developing PTSD, but these studies have been limited by a focus on PTSD in only women
(Watson & Haynes, 2007), small sample sizes (Smyth et al., 2008), or a cross-sectional study
design (Frazier et al., 2009; Netto et al., 2013), and so onset or causality cannot be determined.
PTSD and SUD Comorbidity
Although trauma is most closely associated with PTSD, trauma is a transdiagnostic risk
factor for a variety of conditions, including SUDs. PTSD and SUD comorbidity is common with
estimated prevalence rates of PTSD among individuals with SUD ranging from 25% to 45% or
almost three to five times more likely than in the general population (Dore, Mills, Murray,
Teesson, & Farrugia, 2012; Dragan & Lis-Turlejska, 2007; Gielen, Havermans, Tekelenburg, &
Jansen, 2012; Reynolds, Hinchliffe, Asamoah, & Kouimtsidis, 2011). Individuals with comorbid
PTSD and SUD have an increased risk for more severe symptoms (Peirce, Kindbom, Waesche,
Yuscavage, & Brooner, 2008), other psychiatric problems (i.e., depression, anxiety) (Pietrzak et
al., 2011), suicidality (Pietrzak et al., 2011), morbidity and mortality (Bohnert et al., 2013;
Possemato, Wade, Andersen, & Ouimette, 2010), unemployment (Najavits & Hien, 2013), and
social impairment (Najavits & Hien, 2013). Additionally, the comorbidity is economically
burdensome on the healthcare system, as it results in increased service use (Bowe & Rosenheck,
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2015) and worse treatment prognosis (Mills, Lynskey, Teesson, Ross, & Darke, 2005). A
majority of comorbid PTSD and SUD studies have focused on alcohol, the most commonly cooccurring SUD comorbid with PTSD (Debell et al., 2014), and nicotine (Fu et al., 2007).
However, the literature is much more limited in studies on PTSD and SUD comorbidity that have
focused on cannabis use and CUD specifically.
Trauma Exposure, PTSD, and Cannabis Use Phenotypes
Although the literature on trauma, PTSD, cannabis, and CUD comorbidity is smaller than
that of other substances, there is evidence of associations between these phenotypes found across
multiple study designs: acute increases post-trauma (Vlahov et al., 2002), community (Buckner,
Joiner, Schmidt, & Zvolensky, 2012), clinical (Bonn-Miller et al., 2012; Compton, Simmons,
Weiss, & West, 2011), and epidemiologic (Agosti, Nunes, & Levin, 2002; Kilpatrick et al.,
2000).
In a study examining the acute effects of the September 11, 2001 terrorist attacks among
Manhattan, New York residents, Vlahov and colleagues (2002) saw a 29% increase in substance
use (i.e., alcohol, nicotine, cannabis) 5-8 weeks after the attack. Specifically, 3.2% of local
residents reported an increase in cannabis use during the acute post-disaster period (Vlahov et al.,
2002). Additionally, an increase in cannabis use was associated with an increased likelihood of
developing PTSD compared to no use or no increase (36.0% versus 6.6%) (Vlahov et al., 2002).
Results suggest that cannabis use increases after acute trauma exposure, but research in a more
representative sample is required to investigate the relationship between trauma exposure and
cannabis use more broadly.
The NCS-R is one of the few epidemiologic studies that examined co-occurring trauma
and substance use phenotypes (Kessler, Chiu, Demler, Merikangas, & Walters, 2005). However,
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one limitation of the NCS-R is that the results were not specific to cannabis use phenotypes, and
were instead focused on substance use broadly in relation to PTSD. This study found that a
diagnosis of DSM-IV PTSD was significantly related to a diagnosis of a DSM-IV substance use
disorder (e.g., alcohol or drug) (Kessler, Chiu, et al., 2005). In another epidemiologic study,
Kevorkian and colleagues (2015) examined the relationship between trauma exposure, PTSD,
and cannabis use phenotypes and found that a lifetime history trauma exposure was associated
with a 1.2 increased likelihood of lifetime cannabis use. Additionally, among those endorsing
lifetime trauma exposure and cannabis use lifetime PTSD was associated with a 1.2 increased
likelihood of CUD. In a large representative sample of U.S. adults who reported data on current
and lifetime psychiatric diagnoses and answered questions related to lifetime and current
cannabis use from the NCS-R, Cougle and colleagues (2011) found that lifetime PTSD was
associated with greater odds of lifetime, past-year, and daily cannabis use above and beyond
demographic and psychiatric correlates, such as sex, ethnicity, age, and trauma load.
Specifically, individuals with a lifetime and past-year PTSD were 3.3 and 3.4 times more likely
to have lifetime cannabis use, respectively (Cougle et al., 2011). Interestingly, Cougle and
colleagues (2011) also found that 50.4% of individuals with both a lifetime PTSD diagnosis and
lifetime cannabis use reported that their PTSD onset preceded or occurred at the same time as the
first time they used cannabis. These results suggest a potentially causal relationship between
trauma and cannabis phenotypes. However, this relationship has primarily been studied in crosssectional epidemiological studies. Given the greater than chance relationship between posttrauma psychopathology and cannabis use phenotypes, smaller clinical samples have been
studied to examine the co-occurrence more closely.
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In a sample of veterans receiving care in the Veterans Affairs Health Care System, BonnMiller and colleagues (2012) found that the prevalence of CUD diagnoses have increased from
0.66% to 1.05% between 2002 and 2009, which is more than a 50% increase over 7 years.
Additionally, the prevalence of patients with a CUD diagnosis but no other illicit SUD diagnosis
increased from 0.27% to 0.58% between 2002 and 2009, which is more than a 115.41% increase
during the same time period. Of those individuals with a CUD, but no other illicit SUD
diagnosis, 23%, 27%, and 29% also met diagnostic criteria for PTSD in 2002, 2008, and 2009,
respectively. Results indicate that the rate of PTSD and CUD comorbidity is increasing. It
remains unclear if PTSD comorbidity among individuals with CUD are causes, consequences, or
correlates of CUD, but further investigation of the association is necessary.
Trauma exposure and PTSD are highly related to substance use phenotypes (Jacobsen,
Southwick, & Kosten, 2001), and cannabis use phenotypes are increasing among individuals
with PTSD (Bonn-Miller et al., 2012; Cougle et al., 2011). Given the associations between PTSD
and cannabis use phenotypes, there have been numerous theories that have attempted to address
the high rates of co-occurrence. Co-occurrence of these two conditions may begin when a person
attempts to self-medicate their PTSD symptoms, or cannabis use could lead to PTSD if the
person experiences trauma caused by their cannabis use, like a car accident or physical violence
(Chilcoat & Breslau, 1998). Although cannabis is being considered as a potential mental health
treatment to ease distressing symptoms in individuals with PTSD, the drug may enhance some
symptoms associated with PTSD, making the condition worse (Shishko, Oliveira, Moore, &
Almeida, 2018).
The Self-Medication Hypothesis
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The self-medication hypothesis is the most prominent and widely accepted phenotypic
model of comorbidity that is thought to explain the development of comorbid PTSD and SUD
(Khantzian, 1985). The self-medication hypothesis purports that individuals with trauma
exposure and/or PTSD engage in substance use in an effort to alleviate negative symptoms of the
disorder and consequently develop a SUD (i.e., PTSD to SUD). Longitudinal research has found
that PTSD symptoms often have an earlier onset than SUD symptoms (Bremner, Southwick,
Darnell, & Charney, 1996), lending support to the purported order of onset of the self-medication
hypothesis. Another prominent example of the dynamic relationship between PTSD and SUD
was found over a 26-week period where increases in PTSD symptoms were positively associated
with increases in SUD symptoms (Ouimette, Read, Wade, & Tirone, 2010). Ouimette and
colleagues’ (2010) research suggests that individuals’ substance use symptoms are tied to their
PTSD symptoms and that they could be showing signs of using substances in response to their
increase in distressing PTSD symptoms. A majority of the PTSD and SUD studies that have
attempted to test the tenants of the self-medication hypothesis have been conducted on drug use
broadly (Reed, Anthony, & Breslau, 2007), alcohol (Breslau, Davis, & Schultz, 2003; Jacobsen
et al., 2001), nicotine (Breslau et al., 2003; Cook, Jakupcak, Rosenheck, Fontana, & McFall,
2009), or cocaine (Jacobsen et al., 2001), but fewer studies have examined the relationship
between PTSD and cannabis use phenotypes.
Those exposed to trauma are at a higher risk of using cannabis than individuals without a
history of exposure to trauma (Kevorkian et al., 2015). Additionally, individuals with PTSD are
at an increased risk for CUD (Cornelius et al., 2010). Cornelius and colleagues (2010) found that
the average age of onset of PTSD was 15.4 +/- 5.6 years and the average age of onset of CUD
was 16.7 +/- 2.3 years among trauma exposed adolescents. Cornelius and colleagues’ (2010)
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results suggest that PTSD contributes to the etiology of CUD. Further supporting the selfmedication hypothesis for PTSD and CUD, individuals report using cannabis to regulate
negative emotions, or help cope with intrusive PTSD symptoms (Bonn-Miller, Vujanovic,
Boden, & Gross, 2011). Research suggests that individuals could be using cannabis to selfmedicate their PTSD symptoms, but more research is still needed to provide a more
comprehensive evaluation of the unique associations between trauma exposure, PTSD, and
cannabis use phenotypes.
Not all studies have results that are consistent with the self-medication hypothesis in
relation to PTSD and SUD. Breslau and colleagues (2003) did not find supporting evidence for
self-medicating relationship between PTSD and alcohol use. Specifically, exposure to trauma in
individuals with and without a diagnosis of PTSD did not predict alcohol abuse or dependence in
a longitudinal study of young adults (Breslau et al., 2003). In a study examining the relationship
between specific PTSD symptom clusters and substance use, Tull and colleagues (2010) found
contradicting evidence against the self-medication hypothesis. Specifically, no evidence was
found for a specific relationship between any of the PTSD symptom clusters and cocaine or
alcohol (Jakupcak et al., 2010). Although the self-medication hypothesis is the most prominent
phenotypic model of comorbid PTSD and SUD, it is possible for the relationship to be in the
opposite direction.
The High-Risk and Susceptibility Hypotheses
The high-risk and susceptibility hypotheses are explanations for how comorbid PTSD
and SUD develop that are based on the opposite causal direction for the relationship compared to
the self-medication hypothesis (i.e., SUD to PTSD). The high-risk hypothesis states substance
use behaviors are assumed to increase an individual’s risk of exposure to potentially traumatic
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events and consequentially increases their risk of developing PTSD. Substance use may increase
risk for exposure to a traumatic event by placing individuals in high-risk situations or by
impairing recognition of danger cues in the environment (Davis, Stoner, Norris, George, &
Masters, 2009; Windle, 1994). The susceptibility hypothesis states that substance use increases
the likelihood of developing PTSD after being exposed to a traumatic event (Chilcoat & Breslau,
1998). Individuals who use substances may be less able to manage peri- or post-trauma negative
emotions because the substance use is likely to interfere with their ability to effectively manage
increased anxiety and arousal levels or be a method of avoidance and lack of processing (Kaysen
et al., 2011; Stewart, Pihl, Conrod, & Dongier, 1998). For example, individuals with a SUD were
more likely to meet criteria for PTSD than individuals without a SUD following the Oklahoma
City bombing (North et al., 1999). More recently, individuals with a history of problematic
alcohol use were more likely to have more severe PTSD symptoms following an assault
compared to those without a history of problematic alcohol use (Kaysen et al., 2006). Research
has shown that age of onset of substance abuse precedes PTSD in cocaine abusing individuals
and that the trauma is likely to be associated with the procurement and use of the drug opposed
to childhood trauma (Brady, Dansky, Sonne, & Saladin, 1998). In a study investigating patients
with SUD and the association with development of PTSD, cannabis use was the third most
commonly reported drug of concern with 36% of the total sample reporting problematic use and
40.9% of those with co-occurring PTSD reported cannabis as their principal drug of concern
(Dore et al., 2012). A majority of the supporting studies are cross-sectional and focus on other
substances (i.e., alcohol, cocaine) besides cannabis, which limits the generalizability of their
findings, and thus, longitudinal studies are needed for examining the natural course of
associations between trauma and cannabis phenotypes.
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Shared Risk Model
Research also suggests that the comorbidity of PTSD and CUD may represent a shared
vulnerability. The shared risk model hypothesizes that individuals with greater common liability
for PTSD and CUD are more likely to develop both disorders (Krueger & Markon, 2006). Both
PTSD and SUDs are genetically influenced. Lyons and colleagues (1993) found that heritability
estimates ranged from 35% to 47% for combat exposure among a large sample of Vietnam maletwin veterans. In civilian twin study, Stein and colleagues (2002) also found modest heritability
for IPT (e.g., robbery, sexual assault), whereas exposure to accidental trauma (e.g., motor vehicle
accident, natural disaster) was best explained by environmental influences. Beyond genetic
influences on trauma exposure itself, PTSD is also moderately heritable with estimates ranging
from 30% (Stein et al., 2002) to 72% (Sartor et al., 2011) for PTSD. Cannabis use phenotypes
are also moderately influenced by genetic factors (31% for cannabis use; (Ystrom, ReichbornKjennerud, Neale, & Kendler, 2014), and range from 45-79% for CUD (Agrawal & Lynskey,
2006; Ystrom et al., 2014). Beyond the individual genetic influences on each phenotype, twin
studies also suggest that some of the genes that account for risk may overlap. Wolf and
colleagues (2010) examined the factor structure of PTSD and SUDs in a large study of over
3,000 twin pairs and found that common genetic liability exists between PTSD and SUDs. Xian
and colleagues (2000) also investigated whether and to what degree genetic and environmental
contributions overlap among PTSD, alcohol use disorders (AUD) and SUDs in a large study of
over 3,000 veteran twin pairs and found that about 15% of genetic risk for PTSD was shared
among AUDs and SUDs. Although not specific to cannabis use phenotypes, Xian and
colleague’s (2000) results suggest that PTSD and CUD share common risk. This shared genetic
influence may in part account for PTSD and CUD comorbidity. However, further research is
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necessary in order to understand shared risk factors for trauma and cannabis phenotypes,
specifically.
Summary
Cannabis use and its associations marks an interesting area of research as legal
restrictions become less stringent (Hall, 1994, 2006). Based on cross-sectional and longitudinal
evidence in other populations, trauma and PTSD seem to be well established as risk factors at
least for initiation of cannabis use and the use of other illicit substances (i.e., alcohol, nicotine,
cocaine). Most PTSD and SUD comorbidity research has been done on other drugs warranting
more research focused specifically on PTSD and CUD comorbidity. Given the vast public health
implication of CUD and PTSD, there is a clinical and research imperative for a better
understanding of the etiology of these co-occurring conditions. Given the inconsistencies within
the literature, continued examination is necessary to clarify our understanding of cannabis use
and its correlates. The majority of research on PTSD and CUD among young adults has been
limited by cross-sectional study design that do not allow a detailed analysis of the dynamic
relationship between trauma exposure, PTSD, cannabis use, and CUD. Given the limitations of
cross-sectional studies with regard to testing the potential causal relations (i.e., self-medication
and high-risk hypotheses) between these phenotypes, longitudinal studies are needed. To date, no
longitudinal studies have simultaneously examined the role of trauma exposure and PTSD for
using cannabis and for developing CUD in young adults and vice versa. This study addresses this
gap in the literature by examining the onset and testing the directional relationship of trauma
exposure and cannabis use phenotypes.
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Current Study
The current study aimed to 1) determine the prevalence and baseline correlates of lifetime
any (i.e., yes/no), experimental (i.e., use 1-5 times), and problematic (i.e., use ≥ 6 times)
cannabis use and lifetime IPT exposure in relation to each other among college students prior to
college enrollment; 2) to examine the self-medication and high-risk hypotheses by investigating
the bidirectional relationship between IPT exposure and cannabis use among college students
over time; 3) further investigate the self-medication and high-risk hypotheses by examining
probable PTSD as a potential mediator in the relationship between IPT exposure and cannabis
use as well as examining IPT exposure as a potential mediator in the relationship between
cannabis use and probable PTSD. It was hypothesized that: (1a) there will be significant
differences in lifetime cannabis use between sexes (i.e., men will be more likely to use compared
to women) and racial groups, (i.e., racial minorities will be more likely to use compared to White
individuals); and (1b) there will be significant differences in lifetime IPT exposure between
sexes (i.e., women will be more likely to experience IPT than men) and racial groups (i.e., racial
minorities will be more likely to experience IPT than White individuals); (2a) lifetime IPT
exposure assessed at year 1 Fall will be positively associated with new onset cannabis use
threshold assessed at year 1 Spring; (2b) lifetime cannabis use threshold assessed at year 1 Fall
will be positively associated with new onset IPT exposure count assessed at year 1 Spring; (3a)
probable PTSD assessed at year 1 Spring will mediate the relationship between IPT exposure
count assessed at year 1 Fall and cannabis use threshold assessed at year 2 Spring; and (3b) IPT
exposure count assessed at year 1 Spring will mediate the relationship between cannabis use
threshold assessed at year 1 Fall and probable PTSD assessed at year 2 Spring.
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Data will be drawn from The Spit for Science: A Virginia Commonwealth University
Student Survey (Dick et al., 2014), a large, representative longitudinal study, to accomplish these
aims.
Methods
Participants
The current study included baseline (i.e., year 1 Fall) and follow-up (i.e., year 1 Spring
and year 2 Spring) data from the first four cohorts of Spit for Science (N=9,889). Data from the
parent study was collected from 2011-2014 when all incoming students aged ≥ 18 years were
invited to participate in a university-wide research study on college behavioral health.
Approximately 2 weeks before arriving on campus, information was mailed to all incoming
students and (separately) to their parents. The week before Welcome Week all eligible students
(age 18 or older) received an e-mail through their university e-mail account inviting them to
participate in the project. Participants were representative of the broader student population
attending Virginia Commonwealth University (VCU), in terms of both sex and race. The VCU
Institutional Review Board (IRB) approved all study procedures and informed consent was
obtained from all study participants. Study data were collected and managed using REDCap
(Research Electronic Data Capture), hosted at VCU. REDCap is a secure, web-based application
designed to support data capture for research studies, providing 1) an intuitive interface for
validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3)
automated export procedures for seamless data downloads to statistical packages; and 4)
procedures for importing data from external sources. Participants completed an online survey
during the Fall of their freshman year in REDCap assessing a variety of factors including
childhood experiences, personality, relationships, and behavior, receiving $10 and a t-shirt as
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compensation. Detailed information concerning recruitment can be found in (Dick et al., 2014).
Measures
Given the large-scale nature of the parent Spit for Science study, measures were
abbreviated to reduce participant burden. Item response theory modeling was used to justify all
scale modifications using data from the first wave of the study. Specifically, by investigating the
item characteristic and information curves, items that resembled the calibrating information for
estimating subjects’ location on the latent factor were removed. If an item was distinct enough
compared with the other items included as indicators of the factor and items that optimally
functioned on the latent continuum, then they were included in the measures. Therefore, items
that provided good discrimination at various locations along the range of the latent factor scale
were utilized to make test administration both practical and feasible. Unless otherwise stated,
given the longitudinal nature of the dataset, each variable described below was calculated the
same way for each time point.
Demographics. Data regarding demographics were drawn from the baseline (year 1 Fall)
survey. These questions included self-reported sex, race, cohort, and age. For sex, men were
coded as 0 and women were coded as 1 in order to compare men to women. For race, 3 dummy
coded variables were created for White, Black, Asian, and Other (i.e., American Indian/Alaska
Native, Hispanic/Latino, Native Hawaiian/Other Pacific, more than one race, unknown, and I
choose not to answer) with White as the reference group in order to make the following
comparisons: White versus Black, White versus Asian, and White versus Other. For cohort, 3
dummy coded variables were created for cohorts one through four with one as the reference
group in order to make the following comparisons: one versus two, one versus three, and one
versus four.
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Cannabis Use. Lifetime use and total times used was measured using items adapted from
the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA) (Bucholz et al.,
1994). Recent cannabis use was assessed using items adapted from Substance Abuse and Mental
Health Service Administration (Substance Abuse and Mental Health Service Administration,
2013). In baseline surveys, participants were asked if they had ever used (yes/no response
options) and, if so, how many times (free response). Use 1-5 times was classified as
“experimental” use and use 6 or more times was classified as “problematic” use, which will be
referred to as the “cannabis use threshold” variable. During their follow-up Spring survey the
first year, participants were asked the same questions about use “since VCU,” roughly
corresponding to past 6 months use. In all other Spring follow-up surveys, participants were
asked the same questions about past 12-months use and number of times used.
Interpersonal Trauma Exposure (IPT). Traumatic event (TE) exposure was assessed at
baseline (e.g., year 1 Fall) using an abbreviated version of the Life Events Checklist (Gray, Litz,
Hsu, & Lombardo, 2004). Participants were asked to report on the occurrence of five different
stressful events: natural disasters, physical assaults, sexual assaults, other unwanted or
uncomfortable sexual experiences, and transportation accidents. Response options were “yes” or
“no” to items regarding whether each stressful event occurred “before the past 12 months”,
“during the past 12 months”, or “never happened to me”. If a participant endorsed that the event
occurred either “before the past 12 months”, or “during the past 12 months”, it was considered a
positive endorsement of TE exposure prior to college. If a participant did not endorse any of the
aforementioned options or reported that the events “never happened to me”, it was considered a
negative endorsement of TE history. Categories were further clustered by interpersonal TEs (i.e.,
physical assaults, sexual assaults, other unwanted or uncomfortable sexual experiences). The

34
clustering created two IPT variables, which were utilized in this study: An IPT endorsement
variable (i.e., yes/no) and an IPT count variable ranging from 0-3 for each type of IPT event. The
same items were utilized during year 1 Spring and yearly Spring follow-ups, however, the
timeframe of reference was altered to appropriately capture events occurring “since VCU” and
“in the past 12 months”, respectively.
Probable PTSD. If a participant endorsed a TE on the Life Events Checklist (Gray et al.,
2004) or the single item derived from stressful events measure (Kendler, Karkowski, & Prescott,
1999) they were prompted to respond to four PTSD screener items (four items; α = .93). The
PTSD screener items were derived from the Primary Care PTSD Screen (PC-PTSD), previously
used in screening PTSD symptoms in primary care settings (Prins et al., 2016). The four items
ask whether the participant has ever experienced: nightmares, attempts to avoid thoughts or
reminders of the potentially traumatic experience, hypervigilance, and feelings of detachment.
The total symptom count (ranging from 0-4) was used as the primary PTSD variable in analyses,
and based on standardized scoring for this measure; endorsement of three or more items was
used as indication of a positive lifetime history of probable PTSD. Cohort 4 is the only cohort
that received the four-item measure of probable PTSD. Cohorts 1 through 3 received a version of
probable PTSD assessment where all four items were asked in one question and endorsement of
any item (e.g., nightmares, attempts to avoid thoughts or reminders of the potentially traumatic
experience, hypervigilance, and feelings of detachment) was used as indication of a positive
lifetime history of probable PTSD. Assessments for cohorts one through four were combined to
create an endorsement of probable PTSD variable (i.e., yes/no), where a score greater than 0
classified as probable PTSD. Response options were coded as 0 and 1, where 0 was indicative of
no probable PTSD and 1 was indicative of probable PTSD.
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Alcohol Use Frequency. Average frequency of alcohol use during the past year was
assessed using the frequency items from the Alcohol Use Disorder Identification Test (AUDIT;
(Bohn, Babor, & Kranzler, 1995). Response options for frequency (“How often do you have a
drink containing alcohol?”) were “never”, “monthly or less”, “2 to 4 times a month”, “2 to 3
times a week”, or “4 or more times a week.” Response options were coded from 0 to 4, where
higher responses were indicative of more frequent alcohol use.
Nicotine Use Frequency. Nicotine use was assessed across 4 categories: cigarettes,
cigars, smokeless tobacco, and hookah. Lifetime use and total quantity consumed was assessed
using items adapted from the SSAGA (Bucholz et al., 1994). Recent (past 30 days) frequency of
use was measured using items adapted from SAMSHA (Substance Abuse and Mental Health
Service Administration, 2013). For each nicotine category, participants were asked how
frequently they used the product in the last 30 days. Answer options were “I did not use,” “Once
or twice,” “A few days (3 to 4 days a month),” “A couple of days a week (5 to 11 days a
month),” “3 times a week (12 to 14 days a month),” “most days of the week (15 to 25 days a
month),” and “daily or almost daily (26 to 30 days a month).” Response options specifically for
cigarette use were coded from 0 to 6, where higher responses were indicative of more frequent
nicotine use.
Data Analytic Plan
Multiple Imputation. Missing data was imputed using the R package “missForest”
(Stekhoven & Buhlmann, 2012). A non-parametric multiple imputation method was applied to
estimate missing data in five binary variables of cannabis use from year 1 Fall, year 1 Spring,
and year 2 Spring. Eight iterations of the imputation process were performed until reaching an
optimal stopping point. The imputation was based on six binary (3 cannabis, 3 alcohol) and nine
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categorical (3 cannabis, 3 nicotine, and 3 alcohol) variables from years 1 to 2. The overall
estimate of imputation error was 0.1459 based on the proportion of falsely classified (PFC)
entries, with the PFC of the six binary variables of cannabis use ranging between 0.00 and
0.0002. It is expected that good performance results of imputation with “missForest” will give a
value close to 0, in contrast with inadequate results returning values close to 1 (Stekhoven &
Buhlmann, 2012). The imputed dataset was used for all analyses.
Overview of Data Analytic Plan. Detailed descriptions of the data analytic plan are
presented prior to the results of each aim. In brief, Aim 1 utilized a multinomial logistic
regression framework in order to test predictors of (1a) experimental and problematic cannabis
use and (1b) lifetime IPT exposure. Aim 2 and Aim 3 utilized cross-lagged path analyses in order
to test the relations among cannabis use, IPT exposure, and probable PTSD. Additionally, Aim
3’s path analyses utilized a mediational framework.
Determination of Statistical Significance. Due to the large number of participants (n =
9889) and research suggesting that p-values become less meaningful with very large samples
(Sullivan & Feinn, 2012), a more stringent significance level (i.e., p < .001) was set to determine
statistical significance.
Aim 1 Analyses. Analyses for Aim 1 examined cross-sectional predictors of (1a) lifetime
experimental and problematic cannabis use and (1b) lifetime IPT exposure assessed at the
beginning of college at year 1 Fall. Specifically, two sets of multinomial logistic regressions
were employed using a model building approach in order to test the hypotheses that (1a) lifetime
IPT exposure is a significant predictor of lifetime experimental and problematic cannabis use
above and beyond covariates and (1b) lifetime cannabis use is a significant predictor of lifetime
IPT exposure above and beyond covariates. Covariates included sex, race, cohort, lifetime IPT
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exposure (in the model predicting experimental and problematic cannabis use), lifetime cannabis
use (in the model predicting IPT exposure), alcohol use frequency, and nicotine use frequency.
Data were analyzed using SPSS Version 24 (IBM Corporation, 2016).

Results
Aim 1 Participant Characteristics
Descriptive statistics are presented in Table 1. The majority of participants in the present
sample reported that they were White (n = 4959, 50.1%) and female (n = 6083, 61.5%).
Participation across all four cohorts was about equal. Prevalence of lifetime IPT and probable
PTSD upon college entry was 35.9% (n = 3549) and 32.2% (n=3186), respectively.

Table 1. Demographic and Clinical Characteristics of Substance Users and Non-Users at Year 1 Fall
Full
No
Cannabis
Alcohol
Nicotine
Cannabis
Cannabis
Sample
Cannabis,
Only
Only
Only
and
and
N = 9889 Alcohol, or
N = 276
N = 2290 N = 213
Alcohol
Nicotine
Nicotine
(2.8%)*
(23.2%)* (2.2%)*
N = 1811
N = 467
N = 1948
(18.3%)*
(4.7%)*
(19.7%)*
Characteristic
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
Race
White
4959
677
153
1065
110
931
118
(50.1%)
(34.8%)
(55.4%)
(46.5%)
(51.6%)
(51.4%)
(25.3%)
Black
1900
527
39
486
32
362
177
(19.2%)
(27.1%)
(14.1%)
(21.2%)
(15.0%)
(20.0%)
(37.9%)
Asian
1640
501
45
462
65
262
7
(16.6%)
(25.7%)
(16.3%)
(20.2%)
(30.5%)
(14.5%)
(1.5%)
Other
1390
243
39
277
6
256
165
(14.1%)
(12.5%)
(14.1%)
(12.1%)
(2.8%)
(14.1%)
(35.3%)
Cohort
1
2707
524
106
731
23
421
169
(27.4%)
(26.9%)
(38.4%)
(31.9%)
(10.8%)
(23.2%)
(36.2%)
2
2481
560
86
588
46
417
40
(25.1%)
(28.7%)
(31.2%)
(25.7%)
(21.6%)
(23.0%)
(8.6%)
3
2391
462
33
505
48
479
121
(24.2%)
(23.7%)
(12.0%)
(22.1%)
(22.5%)
(26.4%)
(25.9%)
4
2310
402
51
466
96
494
137
(23.4%)
(20.6%)
(18.5%)
(20.3%)
(45.1%)
(27.3%)
(29.3%)

Alcohol
and
Nicotine
N = 772
(7.8%)*
n (%)

Cannabis,
Alcohol,
and
Nicotine
N = 2112
(21.4%)*
n (%)

483
(62.6%)
70
(9.1%)
143
(18.5%)
76
(9.8%)

1422
(67.3%)
207
(9.8%)
155
(7.3%)
328
(15.5%)

196
(25.4%)
201
(26.0%)
210
(27.2%)
165
(21.4%)

537
(25.4%)
543
(25.7%)
533
(25.2%)
499
(23.6%)
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Table 1 (cont.). Demographic and Clinical Characteristics of Substance Users and Non-Users at Year 1 Fall
Full
No
Cannabis
Alcohol
Nicotine
Cannabis
Cannabis
Sample
Cannabis,
Only
Only
Only
and
and
N = 9889 Alcohol, or
N = 276
N = 2290 N = 213
Alcohol
Nicotine
Nicotine
(2.8%)*
(23.2%)* (2.2%)*
N = 1811
N = 467
N = 1948
(18.3%)*
(4.7%)*
(19.7%)*
Characteristic
n (%)/M
n (%)/M
n (%)/M
n (%)/M
n (%)/M
n (%)/M
n (%)/M
(SD)
(SD)
(SD)
(SD)
(SD)
(SD)
(SD)
Sex
Men
3806
646
78
986
81
638
232
(38.5%)
(33.2%)
(28.3%)
(43.1%)
(38.0%)
(35.2%)
(49.7%)
Women
6083
1302
198
1304
132
1173
235
(61.5%)
(66.8%)
(71.7%)
(56.9%)
(62.0%)
(64.8%)
(50.3%)
Lifetime IPT
No
6340
1378
177
1647
129
1145
246
(64.1%)
(70.7%)
(64.1%)
(71.9%)
(60.6%)
(63.2%)
(52.7%)
Yes
3549
570
99
643
84
666
221
(35.9%)
(29.3%)
(35.9%)
(28.1%)
(39.4%)
(36.8%)
(47.3%)
Probable
PTSD
No
6703
1371
167
1648
150
1157
384
(67.8%)
(70.4%)
(60.5%)
(72.0%)
(70.4%)
(63.9%)
(82.2%)
Yes
3186
577
109
642
63
654
83
(32.2%)
(29.6%)
(39.5%)
(28.0%)
(29.6%)
(36.1%)
(17.8%)
Note: * = percent of full sample; IPT = Interpersonal trauma; PTSD = Posttraumatic stress disorder

Alcohol
and
Nicotine
N = 772
(7.8%)*
n (%)/M
(SD)

Cannabis,
Alcohol,
and
Nicotine
N = 2112
(21.4%)*
n (%)/M
(SD)

243
(31.5%)
529
(68.5%)

902
(42.7%)
1210
(57.3%)

544
(70.5%)
228
(29.5%)

1074
(50.9%)
1038
(49.1%)

537
(69.6%)
235
(30.4%)

1289
(61.0%)
823
(39.0%)

Aim 1a(i): Prevalence Estimates of Lifetime Cannabis, Nicotine, and Alcohol Use
Among those who reported lifetime cannabis use at year 1 Fall (n = 4498, 45.5%), a
majority reported problematic use (i.e., use ≥ 6 times) opposed to experimental use (i.e., use 1-5
times). Specifically, 2788 participants (28.3%) reported problematic cannabis use and 1718
participants (17.4%) reported experimental cannabis use. Among those who reported lifetime
cannabis, nicotine, and/or alcohol use at year 1 Fall (n = 7941, 80.3%), alcohol use only and
polysubstance use (i.e., cannabis, nicotine, and alcohol) were the most common. Specifically,
2290 participants (23.2%) reported only lifetime alcohol use and 2112 participants (21.4%)
reported lifetime cannabis, alcohol, and nicotine use. 772 participants (7.8%) reported both
lifetime alcohol and nicotine use. 467 participants (4.7%) reported both lifetime cannabis and
nicotine use. 1811 participants (18.3%) reported both lifetime cannabis and alcohol use. 213
participants (2.2%) reported only lifetime nicotine use. 276 participants (2.8%) reported only
lifetime cannabis use. 1948 participants (19.7%) reported no lifetime cannabis, nicotine, or
alcohol use.
Aim 1a(ii): Predictors of Lifetime Experimental and Problematic Cannabis Use
Model Building Approach: Multivariate Analyses Predicting Lifetime Problematic
Cannabis Use
Multinomial logistic regression was used to examine whether demographics, lifetime IPT
exposure, alcohol use, and nicotine use predicts lifetime experimental and problematic cannabis
use assessed at year 1 Fall, compared to never having used. All effect sizes are reported as odds
ratios, which can be interpreted as the relative odds (compared to the reference group of no
lifetime use) of reporting experimental (i.e., 1-5 times) and problematic (i.e., ≥ 6 times) cannabis
use.
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Model 1 (see Table 2) tested sex, race, and cohort as predictors of lifetime experimental
and problematic cannabis use. Sex and cohort were not significant predictors of experimental
cannabis use. Race was a significant predictor of experimental cannabis use. Specifically, White
individuals were more likely to report experimental cannabis use compared to Black and Asian
individuals. Sex, race, and cohort were all significant predictors of problematic cannabis use.
Specifically, men were more likely to report problematic cannabis use compared to women;
White individuals were more likely to report problematic cannabis use compared to Black and
Asian individuals; and individuals from cohort three were more likely to report problematic
cannabis use compared to individuals from cohort one.

Table 2. Model 1: Demographics Predicting Lifetime Experimental and Problematic Cannabis Use
R2

Lifetime
Cannabis Use

Predictor

β

Std.
Wald’s χ2
df
p
OR
95% CI
Error
Sex (M vs. W)
.03
.06
.34
1
.56
1.04
.92-1.16
Race (W vs. B)
.36
.07
24.38
1
<.001
1.44*
1.24-1.66
Race (W vs. A)
1.12
.09
152.52
1
<.001
3.08*
2.57-3.68
a
Experimental
Race (W vs. O)
.25
.09
8.44
1
.004
1.28
1.08-1.51
Cohort (1 vs. 2)
.06
.08
.49
1
.49
1.06
.91-1.23
Cohort (1 vs. 3)
.03
.08
.11
1
.75
1.03
.88-1.20
Model 1
(Demographics)
Cohort (1 vs. 4)
-.24
.08
9.91
1
.002
.78
.67-.91
.07
Sex (M vs. W)
.39
.05
62.84
1
<.001
1.47*
1.34-1.62
Race (W vs. B)
.76
.07
131.28
1
<.001
2.14*
1.88-2.44
Race (W vs. A)
1.44
.08
332.44
1
<.001
4.20*
3.60-4.90
b
Problematic
Race (W vs. O)
.21
.07
8.99
1
.003
1.23
1.07-1.41
Cohort (1 vs. 2)
-.13
.07
3.59
1
.06
.88
.78-1.00
Cohort (1 vs. 3)
-.26
.07
15.11
1
<.001
.77*
.68-.88
Cohort (1 vs. 4)
-.13
.07
3.44
1
.06
.88
.77-1.01
Note: No lifetime cannabis use is the reference group for lifetime experimental and problematic cannabis use comparisons; * = p <
.001; a = use 1-5 times, b = use ≥ 6 times; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O =
Other = 1; cohort 1 = 0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1

Model 2 (see Table 3) expanded the demographic variables in the initial model to include
the effects of lifetime IPT exposure in the prediction of lifetime experimental and problematic
cannabis use. For both experimental and problematic cannabis use, sex and race effects remained
consistent with Model 1 results. Cohort was a significant predictor of experimental cannabis use.
Specifically, individuals from cohort four were more likely to report experimental cannabis use
compared to individuals from cohort one. Lastly, individuals with a history of IPT exposure were
more likely to endorse both cannabis use outcomes.
Model 3 (see Table 4) added the effect of past 30-day nicotine and past year alcohol use
frequency in addition to the variables described in Model 2 in the prediction of lifetime
experimental and problematic cannabis use. Sex, race, cohort, and lifetime IPT exposure were
consistent with Model 2 regarding experimental cannabis use. Alcohol was not a significant
predictor of experimental cannabis use. Nicotine use was a significant predictor of experimental
cannabis use. Specifically, individuals who reported smoking more frequently during the past
month were more likely to report experimental cannabis use. Sex, race, cohort, and lifetime IPT
exposure were consistent with Model 2 regarding problematic cannabis use. Nicotine and alcohol
use were both significant predictors of problematic cannabis use. Specifically, individuals who
reported smoking more frequently during the past month were more likely to report problematic
cannabis use; individuals who reported more frequent alcohol consumption during the past
month were more likely to report problematic cannabis use.

Table 3. Model 2: Demographics and IPT Predicting Lifetime Experimental and Problematic Cannabis Use
R2

Lifetime
Cannabis Use

Predictor

β

Std. Error

Wald’s χ2

df

p

OR

95% CI

Sex (M vs. W)
.09
.06
2.07
1
.15
1.09
.97-1.23
Race (W vs. B)
.36
.07
24.23
1
<.001
1.44*
1.24-1.66
Race (W vs. A)
1.10
.09
146.08
1
<.001
3.02*
2.52-3.61
Race (W vs. O)
.27
.09
9.81
1
.002
1.31
1.11-1.55
Experimentala
Cohort (1 vs. 2)
.03
.08
.11
1
.74
1.03
.86-1.20
Cohort (1 vs. 3)
.00
.08
.00
1
.97
1.00
.85-1.17
Cohort (1 vs. 4)
-.28
.08
12.64
1
<.001
.76*
.65-.88
Model 2
(IPT)
IPT (No vs. Yes)
-.53
.06
84.44
1
<.001
.59*
.53-.66
.10
Sex (M vs. W)
.46
.05
86.98
1
<.001
1.59*
1.44-1.75
Race (W vs. B)
.76
.07
129.06
1
<.001
2.14*
1.88-2.45
Race (W vs. A)
1.41
.08
313.84
1
<.001
4.09*
3.50-4.78
Race (W vs. O)
.24
.07
11.46
1
.001
1.27
1.10-1.45
Problematicb
Cohort (1 vs. 2)
-.17
.07
6.12
1
.01
.85
.74-.97
Cohort (1 vs. 3)
-.30
.07
20.09
1
<.001
.74*
.65-.84
Cohort (1 vs. 4)
-.18
.07
6.62
1
.01
.84
.73-.96
IPT (No vs. Yes)
-.74
.05
230.16
1
<.001
.48*
.43-.52
Note: No lifetime cannabis use is the reference group for lifetime experimental and problematic cannabis use comparisons; * = p <
.001; a = use 1-5 times, b = use ≥ 6 times; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O =
Other = 1; cohort 1 = 0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; IPT = interpersonal trauma, no = 0, yes = 1
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Table 4. Model 3: Demographics, IPT, and Polysubstance Use Predicting Lifetime Experimental and Problematic Cannabis Use
R2

Lifetime
Cannabis Use

Predictor

β

Std. Error

Wald’s χ2

df

p

OR

95% CI

Nicotine
.08
.02
20.82
1
<.001
1.08*
1.05-1.12
Alcohol
.10
.03
9.76
1
.002
1.11
1.04-1.18
Sex (M vs. W)
.07
.06
1.19
1
.28
1.07
.95-1.20
Race (W vs. B)
.31
.08
16.74
1
<.001
1.36*
1.17-1.57
Race (W vs. A)
1.06
.09
134.51
1
<.001
2.90*
2.42-3.47
Experimentala
Race (W vs. O)
.25
.09
8.30
1
.004
1.28
1.08-1.51
Cohort (1 vs. 2)
.02
.08
.07
1
.80
1.02
.87-1.19
Cohort (1 vs. 3)
-.02
.08
.06
1
.81
.98
.84-1.15
Model 3
Cohort (1 vs. 4)
-.28
.08
13.19
1
<.001
.75*
.65-.88
(Substance
IPT (No vs. Yes)
-.51
.06
76.95
1
<.001
.60*
.54-.68
Use)
.20
Nicotine
.22
.01
247.17
1
<.001
1.24*
1.21-1.27
Alcohol
.66
.03
517.02
1
<.001
1.93*
1.82-2.04
Sex (M vs. W)
.36
.05
47.14
1
<.001
1.44*
1.30-1.59
Race (W vs. B)
.47
.07
43.80
1
<.001
1.60*
1.39-1.84
Race (W vs. A)
1.19
.08
205.47
1
<.001
3.29*
2.79-3.87
Problematicb
Race (W vs. O)
.12
.07
2.55
1
.11
1.13
.97-1.30
Cohort (1 vs. 2)
-.10
.07
2.07
1
.15
.90
.79-1.04
Cohort (1 vs. 3)
-.28
.07
15.80
1
<.001
.75*
.66-.87
Cohort (1 vs. 4)
-.12
.07
2.86
1
.09
.88
.76-1.02
IPT (No vs. Yes)
-.64
.05
152.22
1
<.001
.53*
.47-.58
Note: No lifetime cannabis use is the reference group for lifetime experimental and problematic cannabis use comparisons; * = p <
.001; a = use 1-5 times, b = use ≥ 6 times; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O =
Other = 1; cohort 1 = 0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; IPT = interpersonal trauma, no = 0, yes = 1

Post-Hoc Analyses
In an attempt to tease apart the individual effects of nicotine and alcohol regarding
polysubstance use, two additional multinomial logistic regressions were employed. Specifically,
one model examined nicotine use frequency as a predictor of lifetime cannabis use threshold
without alcohol use frequency, and the other model examined alcohol use frequency as a
predictor of lifetime cannabis use threshold without nicotine use frequency.
Model 4 (see Table 5) tested sex, race, cohort, lifetime IPT exposure, and past 30-day
nicotine use frequency as predictors of lifetime experimental and problematic cannabis use.
Findings were consistent with Model 3 such that past 30-day nicotine use frequency remained a
significant predictor of both lifetime experimental and problematic cannabis use. Model 5 (see
Table 6) tested sex, race, cohort, lifetime IPT exposure, and past year alcohol use frequency as
predictors of lifetime experimental and problematic cannabis use. Findings differed from Model
3 such that past year alcohol use frequency became a significant predictor of both lifetime
experimental and problematic cannabis use opposed to only lifetime problematic cannabis use. In
summary, results suggest that past 30-day nicotine use frequency was accounting for a unique
variance when both nicotine and alcohol use frequency were included as predictors of lifetime
experimental cannabis use in Model 3, but alcohol use frequency only accounted for a significant
amount of variance when it was included as a predictor without nicotine use frequency.

Table 5. Post-Hoc Model 4: Demographics, IPT, and Nicotine Use Predicting Lifetime Experimental and Problematic Cannabis Use
R2

Lifetime
Cannabis Use

Predictor

β

Std. Error

Wald’s χ2

df

p

OR

95% CI

Nicotine
.09
.02
25.40
1
<.001
1.09*
1.05-1.13
Sex (M vs. W)
.07
.06
1.18
1
.28
1.07
.95-1.20
Race (W vs. B)
.32
.07
18.59
1
<.001
1.38*
1.19-1.59
Race (W vs. A)
1.08
.09
139.11
1
<.001
2.94*
2.46-3.52
a
Experimental
Race (W vs. O)
.26
.09
9.10
1
.003
1.29
1.10-1.53
Cohort (1 vs. 2)
.02
.08
.09
1
.76
1.02
.88-1.20
Cohort (1 vs. 3)
-.02
.08
.05
1
.82
.98
.84-1.15
Model 4
Cohort (1 vs. 4)
-.29
.08
13.44
1
<.001
.75*
.65-.88
(Nicotine
IPT (No vs. Yes)
-.51
.06
78.44
1
<.001
.60*
.54-.67
Only)
.15
Nicotine
.26
.01
406.21
1
<.001
1.30*
1.27-1.34
Sex (M vs. W)
.38
.05
54.47
1
<.001
1.46*
1.32-1.61
Race (W vs. B)
.59
.07
73.26
1
<.001
1.80*
1.57-2.06
Race (W vs. A)
1.32
.08
263.07
1
<.001
3.73*
3.18-4.37
b
Problematic
Race (W vs. O)
.20
.07
8.03
1
.005
1.23
1.06-1.41
Cohort (1 vs. 2)
-.18
.07
6.93
1
.008
.83
.73-.96
Cohort (1 vs. 3)
-.36
.07
27.40
1
<.001
.70*
.61-.80
Cohort (1 vs. 4)
-.21
.07
9.04
1
.003
.81
.70-.93
IPT (No vs. Yes)
-.67
.05
179.37
1
<.001
.51*
.46-.56
Note: No lifetime cannabis use is the reference group for lifetime experimental and problematic cannabis use comparisons; * = p <
.001; a = use 1-5 times, b = use ≥ 6 times; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O =
Other = 1; cohort 1 = 0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; IPT = interpersonal trauma, no = 0, yes = 1
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Table 6. Post-Hoc Model 5: Demographics, IPT, and Alcohol Use Predicting Lifetime Experimental and Problematic Cannabis Use
R2

Lifetime
Cannabis Use

Predictor

β

Std. Error

Wald’s χ2

df

p

OR

95% CI

Alcohol
.12
.03
14.11
1
<.001
1.13*
1.06-1.20
Sex (M vs. W)
.08
.06
1.98
1
.16
1.09
.97-1.22
Race (W vs. B)
.34
.07
20.99
1
<.001
1.40*
1.21-1.62
Race (W vs. A)
1.08
.09
139.25
1
<.001
2.95*
2.46-3.53
a
Experimental
Race (W vs. O)
.25
.09
8.79
1
.003
1.29
1.09-1.52
Cohort (1 vs. 2)
.03
.08
.10
1
.76
1.03
.88-1.20
Cohort (1 vs. 3)
.00
.08
.00
1
.97
1.00
.85-1.17
Model 5
Cohort (1 vs. 4)
-.27
.08
12.11
1
.001
.76
.66-.89
(Alcohol
IPT (No vs. Yes)
-.52
.06
81.73
1
<.001
.60*
.53-.67
Only)
.18
Alcohol
.73
.03
660.87
1
<.001
2.07*
1.96-2.19
Sex (M vs. W)
.43
.05
68.51
1
<.001
1.54*
1.39-1.70
Race (W vs. B)
.60
.07
72.70
1
<.001
1.81*
1.58-2.08
Race (W vs. A)
1.25
.08
232.77
1
<.001
3.50*
2.98-4.11
b
Problematic
Race (W vs. O)
.14
.07
3.54
1
.06
1.15
.99-1.32
Cohort (1 vs. 2)
-.08
.07
1.41
1
.23
.92
.80-1.06
Cohort (1 vs. 3)
-.23
.07
10.39
1
.001
.80
.70-.92
Cohort (1 vs. 4)
-.09
.07
1.52
1
.22
.92
.80-1.05
IPT (No vs. Yes)
-.69
.05
182.94
1
<.001
.50*
.45-.55
Note: No lifetime cannabis use is the reference group for lifetime experimental and problematic cannabis use comparisons; * = p <
.001; a = use 1-5 times, b = use ≥ 6 times; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O =
Other = 1; cohort 1 = 0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; IPT = interpersonal trauma, no = 0, yes = 1

Aim 1b(i): Prevalence Estimates of Lifetime Interpersonal Trauma Exposure
Among those who reported lifetime IPT exposure at year 1 Fall (n = 3549, 35.9%),
exposure to only one of the three experiences (i.e., physical assault, sexual assault, or other) of
IPT was the most common. Specifically, 2378 participants (67.0%) reported a history of
experiencing one of the three types of IPT. 789 participants (22.2.0%) reported a history of
experiencing two types of IPT. 382 participants (10.8%) reported a history of experiencing all
three types of IPT.
Aim 1b(ii): Predictors of Lifetime Interpersonal Trauma Exposure
Model Building Approach: Multivariate Analyses Predicting Lifetime Interpersonal
Trauma Exposure
Logistic regression was used to examine whether demographics, alcohol use, nicotine
use, and cannabis use predict lifetime IPT exposure assessed at year 1 Fall. All effect sizes are
reported as odds ratios, which can be interpreted as the relative odds (compared to the reference
group of no lifetime IPT exposure) of reporting lifetime IPT exposure.
Model 1 (see Table 7) tested sex, race, and cohort as predictors of lifetime IPT exposure.
Sex, race, and cohort were all significant predictors of lifetime IPT exposure. Specifically,
women were more likely to report a history of IPT exposure compared to men; White individuals
were more likely to report a history of IPT exposure compared to Asian individuals; and cohorts
two, three, and four were less likely to report a history of IPT compared to cohort one.
Model 2 (see Table 8) expanded the demographic variables in the initial model to include
the effects of lifetime cannabis use in the prediction of lifetime IPT exposure. Sex and cohort
were consistent with Model 1 regarding lifetime IPT exposure. Race was no longer a significant
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predictor of lifetime IPT exposure. Individuals who did not report a history of cannabis use were
less likely to report a history of IPT compared to individuals who reported lifetime cannabis use.
Model 3 (see Table 9) added the effect of past 30-day nicotine and past year alcohol use
frequency in addition to the variables described in Model 2 in the prediction of lifetime IPT
exposure. Sex, race, cohort, and lifetime cannabis use were consistent with Model 2 regarding
lifetime IPT exposure. Alcohol was not a significant predictor of lifetime IPT exposure. Nicotine
was a significant predictor of lifetime IPT exposure. Specifically, individuals who reported
smoking more cigarettes during the past month were more likely to report lifetime IPT exposure.

Table 7. Model 1: Demographics Predicting Lifetime Interpersonal Trauma Exposure
R2

Predictor

β

Std.
Wald’s χ2
df
p
OR
95% CI
Error
Sex (M vs. W)
-.35
.04
68.88
1
<.001
.71*
.65-.77
Race (W vs. B)
.10
.05
3.10
1
.08
1.10
.99-1.22
Model 1
Race (W vs. A)
.36
.06
38.08
1
<.001
1.43*
1.28-1.60
(Demographics)
.02
Race (W vs. O)
-.12
.06
4.08
1
.04
.88
.78-1.00
Cohort (1 vs. 2)
.21
.06
14.07
1
<.001
1.23*
1.11-1.38
Cohort (1 vs. 3)
.21
.06
13.31
1
<.001
1.23*
1.10-1.37
Cohort (1 vs. 4)
.24
.06
17.08
1
<.001
1.27*
1.13-1.42
Note: * = p < .001; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O = Other = 1; cohort 1 =
0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1
Table 8. Model 2: Demographics and Cannabis Use Predicting Lifetime Interpersonal Trauma Exposure
R2

Predictor

β

Std.
Error
.04
.06
.06
.06
.06
.06
.06
.04

Wald’s χ2

df

p

OR

95% CI

Sex (M vs. W)
-.40
86.79
1
<.001
.67*
.62-.73
Race (W vs. B)
.00
0.00
1
.99
1.00
.90-1.11
Race (W vs. A)
.16
7.54
1
.006
1.18
1.05-1.33
Model 2
Race (W vs. O)
-.16
6.92
1
.009
.85
.75-.96
(Cannabis Use)
.05
Cohort (1 vs. 2)
.22
15.61
1
<.001
1.25*
1.12-1.40
Cohort (1 vs. 3)
.24
16.91
1
<.001
1.27*
1.13-1.42
Cohort (1 vs. 4)
.27
21.65
1
<.001
1.31*
1.17-1.47
Cannabis
-.66
241.49
1
<.001
.52*
.48-.56
(No vs. Yes)
Note: * = p < .001; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O = Other = 1; cohort 1 =
0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; cannabis = lifetime cannabis use, no = 0, yes = 1

Table 9. Model 3: Demographics and Polysubstance Use Predicting Lifetime Interpersonal Trauma Exposure
R2

Predictor
β
Std. Error Wald’s χ2
df
p
OR
95% CI
Nicotine
.07
.01
39.75
1
<.001
1.08*
1.05-1.10
Alcohol
.07
.02
10.27
1
.001
1.08
1.03-1.13
Sex (M vs. W)
-.43
.04
98.19
1
<.001
.65*
.60-.71
Race (W vs. B)
-.06
.06
1.22
1
.27
.94
.84-1.05
Model 3
Race (W vs. A)
.12
.06
4.21
1
.04
1.13
1.01-1.27
(Substance
.06
Race (W vs. O)
-.18
.06
8.48
1
.004
.83
.74-.94
Use)
Cohort (1 vs. 2)
.23
.06
15.91
1
<.001
1.26*
1.12-1.40
Cohort (1 vs. 3)
.23
.06
15.77
1
<.001
1.26*
1.12-1.41
Cohort (1 vs. 4)
.27
.06
20.78
1
<.001
1.30*
1.16-1.46
Cannabis
-.58
.04
174.63
1
<.001
.56*
.51-.61
(No vs. Yes)
Note: * = p < .001; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O = Other = 1; cohort 1 =
0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; cannabis = lifetime cannabis use, no = 0, yes = 1
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Data Analytic Plan: Aims 2 and 3
Aims 2 and 3 Analyses. Analyses for Aims 2 and 3 used continuous (e.g., cannabis use
threshold and IPT exposure count) predictors and outcomes as well as continuous (e.g., age)
covariates that were mean-centered in order to reduce non-essential multicollinearity and
increase interpretability of the findings (Cohen, Cohen, West, & Aiken, 2003). The cannabis use
threshold variable is an ordered categorical variable (i.e., 0 = no use, 1 = experimental use, 2 =
problematic use) with higher values indicating greater use, however it was treated as continuous
for the purposes of these analyses. Analyses for Aims 2 and 3 also used categorical (e.g., sex)
covariates. Tests for univariate and multivariate outliers in the predictor variables were
performed. Specifically, DFBETAS and studentized deleted residuals were utilized to determine
whether there were any outlying cases (Neter, Wasserman, & Kutner, 1989). Distributional
properties of all continuous variables were analyzed to ensure normal distribution of variables.
Skewness and kurtosis values were examined for continuous variables to ensure that they fell
within acceptable ranges (+/-2, +/-7, respectively; (Byrne, 2013; George & Mallery, 2016)).
Main effects of covariates on the outcome variables (e.g., cannabis use threshold and IPT
exposure count) were analyzed; when main effects of covariates were significant (p < .001) they
were retained in the model. Interactions between covariates and covariates (e.g., sex and age),
covariates and predictors (e.g., sex and cannabis use threshold) for Aims 2 and 3, and predictors
and predictors (e.g., cannabis use threshold and IPT exposure count) specifically for Aim 3 were
tested. Only significant interactions (p < .001) were retained in the model. All models testing
Aims 2 and 3 were estimated in Mplus Version 8 (Muthen & Muthen, 2017), with mediation
within Aim 3 being tested using the Model Indirect function.
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Aim 2 tested the longitudinal associations between cannabis use threshold and IPT
exposure count, over and above covariates. To test Aim 2, cross-lagged path analyses were
conducted to test the hypotheses that (2a) year 1 Fall IPT exposure count is prospectively and
positively associated with year 1 Spring cannabis use threshold and (2b) year 1 Fall cannabis use
threshold is prospectively and positively associated with year 1 Spring IPT exposure count.
Broadly, year 1 Fall cannabis use threshold and IPT exposure count were entered as a priori
predictors of year 1 Spring IPT exposure count and cannabis use threshold, respectively. The
covariates were age, sex, race, cohort, alcohol use frequency, and nicotine use frequency.
Specifically, to test Aim 2a (i.e., longitudinal associations between IPT exposure count and
cannabis use threshold, over and above covariates), significant covariates were entered into the
model, followed by IPT exposure count, in order to test if IPT exposure count predicted cannabis
use threshold over and above covariates. Specifically, to test Aim 2b (i.e., longitudinal
associations between cannabis use threshold and IPT exposure count, over and above covariates),
significant covariates were entered into the model, followed by cannabis use threshold, in order
to test if cannabis use threshold significantly predicted IPT exposure count over and above
covariates.
Aim 3 proposed to model the longitudinal, and indirect, associations among IPT exposure
count, probable PTSD, and cannabis use threshold to test the hypotheses that (3a) probable
PTSD will mediate the relation between IPT exposure count and cannabis use threshold and (3b)
IPT exposure count will mediate the relation between cannabis use threshold and probable
PTSD. Specifically, a model building approach was employed, in which two different mediation
analyses (i.e., one for both parts of Aim 3) were run simultaneously and tested (3a) whether IPT
exposure count is associated with probable PTSD, and in turn increased cannabis use threshold

55
(i.e., self-medication hypothesis), as well as (3b) whether cannabis use threshold is associated
with new IPT exposure count, and in term probable PTSD (i.e., high-risk hypothesis). The
covariates were age, sex, race, alcohol use frequency, and nicotine use frequency. Covariates
significantly associated with the outcomes (p < .001) were retained in the final model. In order to
test study hypotheses, mediation analyses investigated whether the indirect effects of IPT
exposure count on cannabis use threshold through probable PTSD as well as cannabis use
threshold on probable PTSD through IPT exposure count were significant.
Determination of Model Fit. Path analyses rely on several statistical tests in order to
determine the adequacy of model fit to the data. The Root Mean Square Error of Approximation
(RMSEA) is related to residual in the model. RMSEA values range from 0 to 1 with a smaller
RMSEA value indicating better model fit. Acceptable model fit is indicated by an RMSEA value
of 0.06 or less (Hu & Bentler, 1999). The Comparative Fit Index (CFI) compares the fit of a
target model to the fit of a null model. CFI ranges from 0 to 1 with a larger value indicating
better model fit. Acceptable model fit is indicated by a CFI value of 0.90 or greater (Hu &
Bentler, 1999). The Tucker-Lewis Index (TLI) is an incremental fit index preferable for smaller
sample sizes. TLI ranges from 0 to 1 with a larger value indicating better model fit.
Aims 2 and 3 Participant Characteristics
Descriptive statistics are presented in Table 10. Prevalence of experimental and
problematic cannabis use upon college entry (i.e., Year 1 Fall) was 17.4% (n = 1718) and 28.1%
(n = 2780), respectively. Prevalence of lifetime IPT exposure count upon college entry for 1, 2,
and 3 types was 29.2% (n = 2890 for 1 type), 12.5% (n = 1240 for 2 types), and 6.5% (n = 642
for 3 types), respectively. Prevalence of probable PTSD upon college entry was 32.2% (n =
3186). Prevalence of experimental and problematic cannabis use during approximately the past
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six months assessed at Year 1 Spring was 19.1% (n = 1888) and 22.6% (n = 2240), respectively.
Prevalence of new onset IPT exposure count during approximately the past six months assessed
at Year 1 Spring for 1, 2, and 3 types was 16.6% (n = 1645), 4.4% (n = 438), and 1.6% (n = 161),
respectively. Prevalence of probable PTSD assessed at Year 1 Spring was 29.2% (n = 2887).
Prevalence of experimental and problematic cannabis use during approximately the past year
assessed at Year 2 Spring was 17.6% (n = 1744) and 26.9% (n = 2657), respectively. Prevalence
of new onset IPT exposure count during approximately the past year assessed at Year 2 Spring
for 1, 2, and 3 types was 13.9% (n = 1370), 2.4% (n = 234), and 0.6% (n = 62), respectively.
Prevalence of probable PTSD assessed at Year 2 Spring was 30.7% (n = 3035).

Table 10. Clinical Characteristics at Year 1 Fall, Year 1 Spring, and Year 2 Spring
Year 1 Fall
Variable

Category

Year 1 Spring
n (%)

Category

Year 2 Spring

n (%)

Category

n (%)

Cannabis

None

5393 (54.5%)

None

5763 (58.3%)

None

5490 (55.5%)

Use

Experimental

1718 (17.4%)

Experimental

1888 (19.1%)

Experimental

1744 (17.6%)

Threshold

Problematic

2780 (28.1%)

Problematic

2240 (22.6%)

Problematic

2657 (26.9%)

IPT

0

5119 (51.8%)

0

7647 (77.3%)

0

8225 (83.2%)

Exposure

1

2890 (29.2%)

1

1645 (16.6%)

1

1370 (13.9%)

Count

2

1240 (12.5%)

2

438 (4.4%)

2

234 (2.4%)

3

642 (6.5%)

3

161 (1.6%)

3

62 (0.6%)

Probable

No

6703 (67.8%)

No

7004 (70.8%)

No

6856 (69.3%)

PTSD

Yes

3186 (32.2%)

Yes

2887 (29.2%)

Yes

3035 (30.7%)

Note: IPT = Interpersonal Trauma, PTSD = Posttraumatic Stress Disorder

Aim 2 Model Fit
The path analysis, with covariates such as sex, race, age, cohort, and alcohol and nicotine
use, produced a decent to good fitting model χ2 (8) = 530.05, p < .001; RMSEA = 0.08, CFI =
0.92, and TLI = 0.43. To improve model fit, modification indices were considered. However,
paths that were recommended to improve model fit were theoretically irrational (i.e., year 1 Fall
cannabis on year 1 Spring cannabis, year 1 Fall IPT with year 1 Spring cannabis) and were thus
not incorporated into the model. The path coefficients of this model are presented in Table 11.
Aim 2 Outlier Analyses
There were no univariate outliers based on DFBETAS or multivariate outliers based on
studentized deleted residuals (SDRs) (Cohen et al., 2003). The cut-off value for DFBETAS is
2/sqrt(n), where n is the number of observations (n = 9889). No cases exceeded a DFBETAS cutoff value of 0.02, but we removed the top three cases with the largest values of DFBETAS. Since
SDRs have a t-distribution, an SDR of magnitude 3 or more in absolute value will be considered
an outlier. No cases exceed a SDR cut-off value of 3 in absolute value, but we removed the top
three cases with the largest values of SDRs. The model results did not change after the most
influential cases were removed. Thus, the confidence in the findings not being driven by single
cases was increased. Results of the path analysis are presented in Table 11 and detailed below.
Cross-Lagged Panel Model Examining Cannabis Use and IPT Count
Aim 2a: Association between Year 1 Fall IPT and Year 1 Spring cannabis use (Self-Medication
Hypothesis)
Age was not a significant predictor of year 1 Fall cannabis use. Sex was a significant
predictor of year 1 Fall cannabis use, such that women were less likely to report a greater number
of times using cannabis compared to men. Race was a significant predictor of year 1 Fall
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cannabis use, such that Black and Asian individuals were less likely to report a greater number of
times using cannabis at year 1 Fall compared to White individuals. Cohort three was more likely
to report a greater number of times using cannabis at year 1 Fall compared to cohort one. Both
alcohol and nicotine use were significant predictors of year 1 Fall cannabis use, such that
individuals who reported more frequent alcohol and nicotine use were more likely to report a
greater number of times using cannabis at year 1 Fall.
Year 1 Spring cannabis use was predicted by year 1 Fall IPT above and beyond year 1
Fall cannabis use and covariates. Specifically, individuals who reported experiencing more types
of IPT at year 1 Fall were more likely to report a greater number of times using cannabis at year
1 Spring. Race and age were not significant predictors of year 1 Spring cannabis use. Year 1 Fall
cannabis use was a significant predictor of year 1 Spring cannabis use, such that individuals who
reported a greater number of times using cannabis at year 1 Fall were more likely to report a
greater number of times using cannabis at year 1 Spring. Sex was a significant predictor of year 1
Spring cannabis use, such that women were less likely to report a greater number of times using
cannabis compared to men. Cohort three was more likely to report a greater number of times
using cannabis at year 1 Spring compared to cohort one. Alcohol and nicotine use were
significant predictors of cannabis use at year 1 Spring. Specifically, individuals who reported
more frequent alcohol and nicotine use at year 1 Spring were more likely to report a greater
number of times using cannabis at year 1 Spring.
Aim 2b: Association between Year 1 Fall cannabis use and Year 1 Spring IPT (High-Risk
Hypothesis)
Race, cohort, and age were not significant predictors of year 1 Fall IPT count. Sex was a
significant predictor of year 1 Fall IPT count, such that women were more likely to report
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experiencing more types of IPT compared to men. Both alcohol and nicotine use were significant
predictors of year 1 Fall IPT count, such that individuals who reported more frequent alcohol and
nicotine use were more likely to report experiencing more types of IPT at year 1 Fall.
Year 1 Spring IPT count was not predicted by year 1 Fall cannabis use above and beyond
year 1 Fall IPT count and covariates. Sex, race, cohort, age, and alcohol use were not significant
predictors of year 1 Spring IPT count. Year 1 Fall IPT count was a significant predictor of year 1
Spring IPT count, such that individuals who reported experiencing more types of IPT at year 1
Fall were more likely to report experiencing more types of IPT at year 1 Spring. Nicotine use
was a significant predictor of IPT count at year 1 Spring. Specifically, individuals who reported
more frequent nicotine use at year 1 Spring were more likely to report experiencing more types
of IPT at year 1 Spring.

Table 11. IPT Predicting Cannabis Use (Self-Medication Hypothesis) and Cannabis Use Predicting IPT (High-Risk Hypothesis) Path
Analysis Results
Cannabis Use Threshold
Predictors

Y1F
β

S.E.

Sex (Women)

-.05

.01

Race (Black)

-.07

Race (Asian)

IPT Count

Y1S
p

β

Y1F

Y1S

S.E.

p

β

S.E.

p

β

S.E.

p

< .001* -.05

.01

< .001*

.15

.01

< .001*

.01

.01

.41

.01

< .001*

.02

.01

.07

.01

.01

.79

.01

.01

.14

-.17

.01

< .001* -.02

.01

.03

-.03

.01

.001

.01

.01

.45

Race (Other)

-.02

.01

.08

.02

.01

.02

.03

.01

.02

-.01

.01

.25

Age

.00

.01

.67

-.02

.01

.01

.01

.01

.31

-.01

.01

.25

Cohort (2)

.01

.01

.22

.01

.01

.42

-.04

.01

.001

.01

.01

.13

Cohort (3)

.04

.01

< .001*

.05

.01

< .001* -.04

.01

.003

-.01

.01

.75

Cohort (4)

.02

.01

.06

.04

.01

.001

-.04

.01

.001

.01

.01

.15

Alcohol (Y1F)

.23

.01

< .001*

-

-

-

.07

.01

< .001*

-

-

-

Alcohol (Y1S)

-

-

-

.15

.01

< .001*

-

-

-

.02

.01

.05

Nicotine (Y1F)

.17

.01

< .001*

-

-

-

.11

.01

< .001*

-

-

-

Nicotine (Y1S)

-

-

-

.07

.01

< .001*

-

-

-

.03

.01

< .001*

Cannabis (Y1F)

-

-

-

.43

.01

< .001*

-

-

-

.02

.01

.04

IPT (Y1F)

-

-

-

.03

.01

< .001*

-

-

-

.62

.01

< .001*

Note: IPT = Interpersonal Trauma, Sex (Reference: Male), Race (Reference: White), Cohort (Reference: 1), Y1F = Year 1 Fall, Y1S =
Year 1 Spring, * significant at p < .001

Aim 3 Model Fit
The path analysis, with covariates such as sex, race, age, cohort, and alcohol and nicotine
use, produced a poor fitting model χ2 (33) = 6470.76, p < .001; RMSEA = 0.14, CFI = 0.14, and
TLI = -1.07. To improve model fit, modification indices were considered. However, paths that
were recommended to improve model fit were theoretically irrational (i.e., year 1 Fall probable
PTSD on year 2 Spring probable PTSD, year 1 Spring IPT count with year 1 Spring probable
PTSD) and thus were not added to the model. The path coefficients of this model are presented
in Table 12.
Aim 3 Outlier Analyses
There were no univariate outliers based on DFBETAS or multivariate outliers based on
studentized deleted residuals (SDRs) (Cohen et al., 2003). No cases exceeded a DFBETAS cutoff value of 0.02, but we removed the top three cases with the largest values of DFBETAS. No
cases exceed a DFBETAS cut-off value of 3 in absolute value, but we removed the top three
cases with the largest values of SDRs. The model results did not change after the most influential
cases were removed one at a time. Thus, the confidence in the findings not being driven by
single cases was increased. Results of the path analysis are presented in Table 12 and detailed
below.
Cross-Lagged Panel Model Examining Cannabis Use, IPT Count, and Probable PTSD
Aim 3a: Mediational association between Year 1 Fall IPT count, Year 1 Spring probable PTSD,
and Year 2 Spring cannabis use threshold (High-Risk Hypothesis)
Sex was a significant predictor of year 1 Spring probable PTSD, such that women were
more likely to meet criteria for probable PTSD compared to men. Race was a significant
predictor of year 1 Spring probable PTSD, such that Black and Asian individuals were less likely
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to meet criteria for probable PTSD compared to White individuals. Cohorts two, three, and four
were more likely to meet criteria for probable PTSD at year 1 Spring compared to cohort one.
Age was a significant predictor of year 1 Spring probable PTSD, such that older individuals were
more likely to meet criteria for probable PTSD at year 1 Spring. Nicotine use was a significant
predictor of year 1 Spring probable PTSD, such that individuals who reported more frequent
nicotine use were more likely to meet criteria for probable PTSD at year 1 Spring. Alcohol use
was not significant a predictor of probable PTSD at year 1 Spring. IPT count was a significant
predictor of year 1 Spring probable PTSD, such that individuals who reported experiencing more
types of IPT exposure at year 1 Fall were more likely to meet criteria for probable PTSD at year
1 Spring.
Sex, cohort, and age were not significant predictors of year 2 Spring cannabis use. Race
was a significant predictor of year 2 Spring cannabis use, such that Asian individuals were less
likely to report a greater number of times using cannabis compared to White individuals. Both
nicotine and alcohol use were significant predictors of year 2 Spring cannabis use, such that
individuals who reported more frequent nicotine use were more likely to report experimental or
problematic cannabis use at year 2 Spring. IPT count was a significant predictor of year 2 Spring
cannabis use, such that individuals who reported more types of IPT exposure at year 1 Fall were
more likely to report a greater number of times using cannabis at year 2 Spring. Probable PTSD
was not a significant predictor of year 2 Spring cannabis use.
In examining whether year 1 Spring probable PTSD mediated the effect of year 1 Fall
IPT count on year 2 Spring cannabis use, we found that the indirect effect was non-significant (β
= -.01, 95% CI: -.020 - -.002, p = .01). Therefore, year 1 Spring probable PTSD did not mediate
the effect of year 1 Fall IPT count on year 2 Spring cannabis use.

Aim 3b: Mediational association between Year 1 Fall cannabis use threshold, Year 1 Spring IPT
count, and Year 2 Spring probable PTSD (High-Risk Hypothesis)
Sex, race, cohort, age, nicotine use, and cannabis use were not significant predictors of
year 1 Spring IPT count. Alcohol was a significant predictor of year 1 Spring IPT count, such
that individuals who reported more frequent alcohol use were more likely to report experiencing
more IPT at year 1 Spring.
Alcohol and cannabis use were not significant predictors of probable PTSD at year 2
Spring. Sex was a significant predictor of year 2 Spring probable PTSD, such that women were
more likely to meet criteria for probable PTSD compared to men. Race was a significant
predictor of year 2 Spring probable PTSD, such that Other individuals were more likely to meet
criteria for probable PTSD at year 2 Spring compared to White individuals. Cohorts two, three,
and four were more likely to meet criteria for probable PTSD at year 2 Spring compared to
cohort one. Age was a significant predictor of year 2 Spring probable PTSD, such that older
individuals were more likely to meet criteria for probable PTSD at year 2 Spring. Nicotine use
was a significant predictor of year 2 Spring probable PTSD, such that individuals who reported
more frequent nicotine use were less likely to meet criteria for probable PTSD at year 2 Spring.
IPT count was a significant predictor of year 2 Spring probable PTSD, such that individuals who
reported experiencing more types of new onset IPT exposure between year 1 Fall and year 1
Spring were more likely to meet criteria for probable PTSD at year 2 Spring.
In examining whether year 1 Spring IPT count mediated the effect of year 1 Fall cannabis
use on year 2 Spring probable PTSD, we found that the indirect effect was non-significant (β =
.00, 95% CI: -.001 - .003, p = .19). Therefore, year 1 Spring IPT count did not mediate the effect
of year 1 Fall cannabis use on year 2 Spring probable PTSD.

Table 12. Probable PTSD as a Mediator Between IPT and Cannabis Use (Self-Medication Hypothesis) and IPT as a Mediator
Between Cannabis Use and Probable PTSD (High-Risk Hypothesis) Path Analysis Results
Self-Medication Hypothesis
PTSD (Y1S)

Predictors

High-Risk Hypothesis

Cannabis (Y2S)

IPT (Y1S)

PTSD (Y2S)

β

S.E.

p

β

S.E.

p

β

S.E.

p

β

S.E.

p

Sex (Women)

.17

.01

< .001*

-.02

.01

.02

.01

.01

.43

.17

.01

< .001*

Race (Black)

-.06

.01

< .001*

-.02

.01

.05

.02

.01

.10

.00

.01

.76

Race (Asian)

-.06

.01

< .001*

-.05

.01

< .001*

.01

.01

.38

.04

.01

.006

Race (Other)

.01

.01

.66

.00

.01

.95

-.01

.01

.28

.06

.01

< .001*

Cohort (2)

.06

.02

< .001*

.01

.01

.59

.02

.01

.17

.06

.02

< .001*

Cohort (3)

.14

.02

< .001*

.00

.01

.80

-.01

.01

.65

.09

.02

< .001*

Cohort (4)

.15

.02

< .001*

.01

.01

.68

.02

.01

.18

.13

.02

< .001*

Age

.09

.01

< .001*

.01

.01

.64

-.01

.01

.30

.05

.01

< .001*

Nicotine (Y1F)

.08

.02

< .001*

-

-

-

.00

.01

.95

-

-

-

Nicotine (Y1S)

-

-

-

.10

.01

< .001*

-

-

-

-.10

.02

< .001*

IPT (Y1F)

.29

.01

< .001*

.06

.01

< .001*

-

-

-

-

-

-

IPT (Y1S)

-

-

-

-

-

-

-

-

-

.08

.01

< .001*

PTSD (Y1F)

-

-

-

-

-

-

-

-

-

-

-

-

PTSD (Y1S)

-

-

-

-.04

.02

.01

-

-

-

-

-

-

Note: IPT = Interpersonal Trauma, PTSD = Posttraumatic Stress Disorder, Sex (Reference: Male), Race (Reference: White), Cohort
(Reference: 1), Y1F = Year 1 Fall, Y1S = Year 1 Spring, Y2S = Year 2 Spring, * significant at p < .001

Table 12 (cont.). Probable PTSD as a Mediator Between IPT and Cannabis Use (Self-Medication Hypothesis) and IPT as a Mediator
Between Cannabis Use and Probable PTSD (High-Risk Hypothesis) Path Analysis Results
Self-Medication Hypothesis
Predictors

PTSD (Y1S)

High-Risk Hypothesis

Cannabis (Y2S)

IPT (Y1S)

PTSD (Y2S)

β

S.E.

p

β

S.E.

p

β

S.E.

p

β

S.E.

p

Cannabis (Y1F)

-

-

-

-

-

-

.01

.01

.18

.00

.01

.99

Alcohol (Y1F)

.01

.01

.45

-

-

-

.04

.01

<.001***

-

-

-

Alcohol (Y1S)

-

-

-

.10

.01

< .001***

-

-

-

.00

.01

.97

Note: IPT = Interpersonal Trauma, PTSD = Posttraumatic Stress Disorder, Sex (Reference: Male), Race (Reference: White), Cohort
(Reference: 1), Y1F = Year 1 Fall, Y1S = Year 1 Spring, Y2S = Year 2 Spring, * significant at p < .001

Discussion
The aims of the present study were threefold. First, the present study examined the
prevalence and predictors of lifetime cannabis use and lifetime IPT exposure. Second, the selfmedication and high-risk hypotheses were explored by investigating the bidirectional
relationship between IPT count and cannabis use threshold over time. Third, the self-medication
and high-risk hypotheses were further studied using a mediational framework. Specifically, the
self-medication hypothesis was investigated by testing the indirect effect of IPT count onto
cannabis use threshold via probable PTSD. Likewise, the high-risk hypothesis was investigated
by testing the indirect effect of cannabis use threshold onto probable PTSD via IPT count.
Findings from each aim are discussed in turn.
Aim 1a: Prevalence and Predictors of Lifetime Cannabis Use
Overall Summary of Findings
This study estimated the prevalence of lifetime cannabis use and investigated
demographic and clinical characteristics as predictors of lifetime cannabis use, which produced
four main findings. First, results showed that individuals who reported a history of IPT exposure
prior to college were more likely to report lifetime experimental and problematic cannabis use.
Second, results showed evidence for sex differences with respect to lifetime cannabis use, such
that men were more likely to report a history of problematic cannabis use compared to women,
but not experimental cannabis use. Third, results showed evidence for racial differences with
respect to lifetime cannabis use, such that White individuals were more likely to report a history
of experimental and problematic cannabis use compared to Black and Asian individuals. Fourth,
results showed evidence for lifetime alcohol and nicotine use as predictors of lifetime cannabis
use.
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Prevalence of Lifetime Cannabis Use
The present study assessed the prevalence of lifetime experimental and problematic
cannabis use among a large sample of college students at an urban college campus in the
southeastern part of the United States. Overall, 17.4% and 28.3% of participants reported
lifetime experimental and problematic cannabis use, respectively. These findings were consistent
with previous prevalence estimates, which suggested that almost half (45%) of incoming college
students report lifetime cannabis use (Arria et al., 2017). Our study separated lifetime cannabis
use into categories based on total number of times used (i.e., experimental = use 1-5 times,
problematic = use ≥ 6 times), but combined, almost half (45.7%) of study participants reported a
history of either category of cannabis use upon college entry.
Predictors of Lifetime Cannabis Use
The present study also examined predictors of lifetime experimental and problematic
cannabis use. Lifetime IPT exposure was hypothesized to predict lifetime cannabis use above
and beyond demographic and substance use covariates. Consistent with previous research
(Kevorkian et al., 2015; Konkoly Thege et al., 2017; Werner et al., 2016), results show that
individuals who reported lifetime IPT exposure were more likely to report lifetime experimental
and problematic cannabis use. IPT is a stronger predictor of psychopathology compared to
accidental trauma (Frans et al., 2005; Kilpatrick et al., 2013). Although previous research
supports trauma exposure broadly predicting cannabis use (Kevorkian et al., 2015), results from
this study support IPT exposure as a category of trauma exposure that is a predictor of increased
risk for cannabis use. Similar to Kevorkian and colleagues (2015), alcohol, but not nicotine, was
included as a predictor of cannabis use along with trauma exposure. However, a recent study
investigating the co- and tri-use of cannabis, cigarettes, and alcohol without trauma as a predictor
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found that the use of cannabis, cigarettes, or alcohol independently increased the probability of
subsequent, simultaneous co-use of one of the two remaining substances (Roche et al., 2019).
Therefore, our study expanded the literature by including both alcohol and nicotine as predictors
of cannabis use in order to help demonstrate that IPT is associated with increased risk over other
established correlates.
As hypothesized, demographic factors were associated with risk of reporting lifetime
cannabis use. Regarding sex, it was hypothesized that men would be more likely to report a
history of cannabis use compared to women. Results show that men were more likely to report
lifetime problematic cannabis use compared to women, but men and women were equally likely
to report lifetime experimental cannabis use. Results align with previous research, which
suggests that men are more likely to use cannabis than women, and the differences tend to be
most severe at higher frequency levels (Carliner et al., 2017; Johnston et al., 2016; Substance
Abuse and Mental Health Services Administration, 2016). This sex gap regarding cannabis use
could be due to both biological and sociological differences, such as how cannabis use affects the
body, addiction stigma, and societal expectations about emotional expression. Results also
mirrored similar epidemiologic research that examined sex differences in prevalence of CUDs
(Kerridge, Pickering, Chou, Saha, & Hasin, 2018). Therefore, results expanded the literature by
demonstrating the level of use (i.e., experimental versus problematic) where sex differences are
more likely to be detected among college students.
While there were racial differences among those who were more likely to report lifetime
cannabis use, the racial differences were not in the hypothesized direction. Specifically, it was
hypothesized that individuals belonging to racial minority groups would be more likely to report
cannabis use compared to White individuals. Results show that White individuals were more
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likely to report both experimental and problematic cannabis use compared to Black, Asian, and
Other individuals. Regarding race as a predictor of cannabis use, previous research shows that
racial and ethnic minority individuals are more likely to report using cannabis compared to
White individuals (Pacek et al., 2012; Warner, 2016). Therefore, the race results of this study are
inconsistent with previous research suggesting that racial minority individuals are less likely to
use cannabis compared to White individuals. Among adolescents on the trajectory to college,
recent epidemiological study results show a trend that cannabis use is increasing in the United
States among non-White adolescents in the 10th through 12th grades (Keyes, Wall, Feng, Cerda,
& Hasin, 2017). These self-report survey procedures have been shown to enhance valid reporting
by collecting data via non-school-associated university personnel. While Spit for Science is also
collected via self-report, it is subject to potentially more bias and error due to its affiliation with
the university, which provides a possible explanation for the inconsistent findings. However,
consistent with previous research (Johnson et al., 2015), results showed that Asian individuals
were the racial group least likely to report cannabis use. Regardless of the levels of cannabis use
among racial and ethnic minorities, these individuals are still more likely than White individuals
to experience negative consequences of cannabis use, including CUD, negative psychosocial
outcomes, and academic difficulties (Blavos et al., 2017; Edwards et al., 2015).
Additional covariates were explored as predictors of lifetime cannabis use. Cohorts 3 and
4 were more likely to report lifetime problematic and experimental cannabis use, respectively,
compared to cohort 1. These results are consistent with previous research suggesting that the
overall prevalence of lifetime cannabis use is increasing among individuals 12 years and older
and that younger generations are more likely to use cannabis compared to older generations due
to increasing acceptance and legalization rates (Kilmer & MacCoun, 2017; Substance Abuse and
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Mental Health Services Administration, 2016). In a related study investigating alcohol
consumption and drinking to cope with trauma-related distress in the same sample, latter cohorts
were overall more risky regarding their alcohol use (Bountress et al., 2019). Results from this
study extended their overall more risky behavior to include cannabis use.
Legal substances, such as nicotine and alcohol, were explored as predictors of lifetime
cannabis use. Individuals who reported more frequent nicotine use during the past month were
more likely to report lifetime experimental cannabis use. Additionally, individuals who reported
more frequent nicotine use during the past month and more frequent alcohol use during the past
year were more likely to report lifetime problematic cannabis use. Post-hoc analyses revealed
that individuals who reported more frequent alcohol use during the past year were more likely to
report both lifetime experimental and problematic cannabis use when past 30-day nicotine use
frequency was not included as a predictor. These results are consistent with previous
epidemiological research suggesting that cannabis use is more common among people who
smoke cigarettes than among those who do not (Goodwin et al., 2018). However, results extend
the literature by showing more frequent nicotine use is a better predictor of lifetime cannabis use
among individuals with both frequent nicotine and alcohol use, which could be due to the similar
route of administration (i.e., inhalation). Although a majority of previous research supports the
association between more severe phenotypes such as lifetime nicotine use, alcohol use, and
cannabis use disorders (Grant et al., 2016; Kevorkian et al., 2015), these results are still
consistent such that a history of alcohol and nicotine are predictors of increased risk for lifetime
cannabis use.
Aim 1b: Prevalence and Predictors of Lifetime IPT Exposure
Overall Summary of Findings
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This study estimated the prevalence of lifetime IPT exposure and investigated
demographic and clinical characteristics as predictors of lifetime IPT exposure, which produced
four main findings. First, results showed cross-sectional support for the high-risk hypothesis,
such that individuals who reported a history of cannabis use were more likely to report lifetime
IPT exposure. Second, results showed evidence for sex differences with respect to lifetime IPT
exposure, such that women were more likely to report a history of IPT exposure compared to
men. Third, results showed that all racial groups were equally likely to report a history of
lifetime IPT exposure. Fourth, results showed evidence for nicotine use as a predictor of lifetime
IPT exposure.
Prevalence of Lifetime IPT Exposure
The present study assessed the prevalence of lifetime IPT exposure among college
students. Overall, 35.9% of participants reported lifetime IPT exposure. This study’s findings
were inconsistent with previous prevalence estimates, which suggested that about 50.6% of
college students reported a history of IPT exposure (Read, Griffin, Wardell, & Ouimette, 2014).
This inconsistency is likely due to the different ways trauma exposure was assessed. Read and
colleagues (2014) used the Traumatic Life Events Questionnaire (TLEQ) to assess trauma
exposure compared to Spit for Science’s Life Events Checklist (LEC). In contrast, 11 out of the
21 items of the TLEQ map onto the definition of IPT opposed to 3 out of the 5 items of the
modified LEC used in the present study. This lower prevalence estimate based on this study were
likely due to lack of inclusion of other categories of IPT that are included in other measures, such
as the TLEQ.
Predictors of Lifetime IPT Exposure
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The present study also assessed predictors of lifetime IPT exposure. Lifetime cannabis
use was hypothesized to predict lifetime IPT exposure above and beyond demographic and
clinical covariates. Consistent with previous research investigating the association between
lifetime cannabis use and lifetime trauma exposure (Kevorkian et al., 2015), results show that
individuals with a history of cannabis use were more likely to report lifetime IPT exposure.
As hypothesized, there were demographic differences among those who were more likely
to report lifetime IPT exposure. Results were consistent with the hypothesis that women would
be more likely to report a history of IPT compared to men. Results align with previous research,
which suggests that women are more likely to experience IPT than men in both college (Fedina,
Holmes, & Backes, 2018; Read et al., 2011) and non-college (Benjet et al., 2016; Lilly &
Valdez, 2012) samples. Results add to the substantial evidence that sex differences are universal
regarding IPT exposure and that the college environment is no exception.
It was hypothesized that individuals belonging to racial minority groups would be more
likely to report a history of IPT exposure compared to White individuals. Contrary to hypotheses,
results indicate that there were no racial differences among those who reported lifetime IPT
exposure. Although previous research has shown significant differences in IPT exposure across
different racial and ethnic groups (Roberts et al., 2011), this study’s results show that all college
students, regardless of race, are equally likely to report lifetime IPT exposure prior to college
enrollment. This inconsistency is likely due to the different ways trauma exposure was assessed.
Roberts and colleagues (2011) used data from structured diagnostic interviews of the National
Epidemiologic Survey on Alcohol and Related Conditions (NESARC) to assess lifetime trauma
exposure compared to Spit for Science’s LEC. In contrast, at least 6 out of the 27 items of the
NESARC map onto the definition of IPT opposed to 3 out of the 5 items of the LEC. The equal
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likelihood of individuals of different racial backgrounds having a history of IPT exposure based
on this study could be due to having less specific and a lower variety of potential IPT events for
participants to choose from during self-reported assessment of lifetime trauma exposure. Another
possible explanation for the inconsistencies is that there may not be racial differences in IPT
exposure among those seeking higher education compared to the general population. In a study
examining trauma exposure of newly matriculated college students, Read and colleagues (2011)
found that individuals from a non-White racial background were at higher risk for IPT exposure
compared to White individuals. However, individuals who reported identifying as Black, Asian,
Hispanic/Latino, American-Indian/Alaskan, Hawaiian/Pacific Islander, and Multiracial were
grouped together for statistical analyses due to not ideal percentages of representation in most
groups (i.e., < 10%). It is possible that racial differences may not have been found if analyses
were conducted separately by larger racial groups.
Additional covariates were explored as predictors of lifetime IPT exposure. Cohorts 2, 3,
and 4 were less likely to report a history of IPT exposure compared to cohort 1. Additionally,
individuals who reported more frequent nicotine use during the past 30 days were more likely to
report lifetime IPT exposure. These results are consistent with previous research, which indicate
that current- and ever-smokers have increased odds of reporting experiencing traumatic events
compared to never-smokers (Hapke et al., 2005). (Jamal et al., 2014), those who continue to
smoke cigarettes could be classified as more risky individuals, and perhaps this may partially
account for the increased risk for IPT exposure. Additionally, these analyses are cross-sectional,
and thus order of onset cannot be determined. Thus, it could be that smoking behavior occurred
subsequent to IPT exposure. There is a wealth of literature on increased smoking behaviors
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among trauma and PTSD populations (Gabert-Quillen, Selya, & Delahanty, 2015; Kearns et al.,
2018; Pericot-Valverde, Elliott, Miller, Tidey, & Gaalema, 2018).
Aim 2: Longitudinal Investigation of the Self-Medication and High-Risk Hypotheses
Overall Summary of Findings
The associations between lifetime cannabis use and lifetime IPT exposure speaks to the
self-medication (Boden, Babson, Vujanovic, Short, & Bonn-Miller, 2013) and high-risk
(Ramaekers, Berghaus, van Laar, & Drummer, 2004) hypotheses. According to the selfmedication hypothesis, cannabis use may serve as an avoidance function for those with an IPT
history and could be coping with trauma-related symptoms. Conversely, the high-risk hypothesis
purports that using cannabis may lead to higher risk for experiencing trauma exposure. The selfmedication and high-risk hypotheses can be used as a lens to try to understand the associations
among cannabis use, trauma exposure, and PTSD, with longitudinal analyses allowing for
methods by which one could examine links in these pathways. This study used these etiologic
models of comorbid cannabis use and trauma-related phenotypes to investigate the relationships
between lifetime IPT exposure and new onset cannabis use and lifetime cannabis use and new
onset IPT exposure during the first year of college. Results supported the direction of effect from
IPT to cannabis use, supporting the self-medication hypothesis, but not from IPT to cannabis use,
not lending support to the high-risk hypothesis.
Self-Medication Hypothesis
Path analyses suggest that IPT exposure is a significant predictor of cannabis use above
and beyond race, age, nicotine, alcohol, and previous cannabis use. These results are consistent
with previous research, which suggests that trauma exposure tends to precede, rather than follow,
the development of lifetime cannabis use and cannabis use problems (Kevorkian et al., 2015),
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specifically IPT (Browne, Dolan, Simpson, Fortney, & Lehavot, 2018; Werner et al., 2016).
Results from the current study expanded the trauma-related and cannabis use phenotypes
self-medication literature with the use of longitudinal data and a college sample. Kevorkian and
colleagues (2015) used a nationally-representative sample of adults in the U.S. to examine the
association between lifetime trauma exposure, PTSD, cannabis use, and CUD and found that
individuals exposed to trauma are at a higher risk of using cannabis or developing cannabis use
problems compared to individuals without a history of trauma exposure. Although the direction
of effect cannot be determined due to the cross-sectional nature of the study, results suggest that
because trauma-exposed individuals had higher odds of reporting cannabis use than non-trauma
exposed individuals, there is a unique association between trauma exposure and cannabis use
(2015). Werner and colleagues (2016) utilized data from a longitudinal study investigating
alcohol-related problems and associated psychopathology in order to examine the direction of
effect between trauma exposure and cannabis use. Specifically, Werner and colleagues (2016)
examined the contribution of first reported age of onset given for trauma exposures to cannabis
initiation in an all-female emerging adult twin sample. Results suggest that trauma exposure is an
important contributor to cannabis initiation and provide support for the self-medication
hypothesis posited to explain the development of comorbid PTSD-CUD. However, Werner and
colleagues’ (2016) results are limited by their use of an all-female sample and their reliance on
retrospective self-report for the longitudinal nature of their study. In another all-female sample,
Browne and colleagues (2018) examined the independent contributions of sexual trauma on pastyear cannabis use including alcohol and tobacco use as covariates. Cross-sectional results
revealed that regular cannabis use is common among individuals who had experienced sexual
trauma, individuals with higher PTSD symptoms, and individuals reporting alcohol or tobacco
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use. However, Browne and colleagues’ (2018) results are limited by their use of an all-female
and veteran sample. The current study combined previously supported associations and
covariates to investigate patterns between trauma exposure and cannabis use. Overall, the
current study results reveal that trauma exposure, specifically IPT, may be an important
contributor to cannabis use, but suggest the importance of considering sex and polysubstance use
when developing etiologic models of trauma-related phenotypes predicting cannabis use
phenotypes.
High-Risk Hypothesis
Path analyses did not suggest that cannabis use is a significant predictor of IPT exposure.
A majority of previous research on the functional relationship between substance use and trauma
exposure has focused on substances besides cannabis (i.e., alcohol, cocaine) (Brady et al., 1998;
Kaysen et al., 2006), but limited evidence on the longitudinal relationship between substance use
and IPT exposure suggests that the misuse of cocaine may be associated with subsequent trauma
exposure and post-trauma psychopathology (Brady et al., 1998). While the directionality of our
results from Aim 1 cannot be determined, they demonstrated an association between lifetime
cannabis use and lifetime IPT exposure similar to other studies examining the functional
relationship between cocaine use and trauma-related psychopathology (Brady et al., 1998).
However, our results do not show support for the prospective association between lifetime
cannabis use potentially influencing new onset IPT exposure.
Previous studies examining trauma-related and substance use phenotypes from a highrisk hypothesis framework found a functional relationship between substance use and trauma
exposure. For example, Davis and colleagues (2009) examined the effects of alcohol on
women’s sexual assault risk perception and found that alcohol may increase women’s sexual
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victimization likelihood through reduced sexual assault risk perception. Studies comparing
behavioral effects of alcohol and cannabis use found that alcohol use caused more impairment
than cannabis use at higher doses (Heishman, Arasteh, & Stitzer, 1997; Heishman, Stitzer, &
Bigelow, 1988). One possible explanation the current study did not find a significant association
between cannabis use and new onset IPT exposure could be that other substances, such as
cocaine and alcohol, have more behavioral effects on the body than cannabis use at higher usage
levels. Another possible explanation the current study did not find a significant association
between cannabis use and new onset IPT exposure could be due to measurement error. It is
possible that greater amounts or more frequent cannabis use is associated with a greater
likelihood of new onset IPT exposure and the way cannabis use was measured in S4S cannot
differentiate between low and high levels of use. There is a need for both more research on the
effects of cannabis use on behavior effects and longitudinal studies investigating the effects of
cannabis use on future trauma exposure.
Aim 3: Mediational Investigation of the Self-Medication and High-Risk Hypotheses
Overall Summary of Findings
A high rate of comorbidity clearly exists between PTSD and CUD (Bonn-Miller et al.,
2012; Cougle et al., 2011; Kevorkian et al., 2015; Vlahov et al., 2002). Trauma exposure,
specifically IPT, is highly likely to lead to PTSD; likewise, individuals who engage in substance
use behaviors have been shown to have a higher likelihood of developing PTSD potentially due
to an increase in risky behavior compared to individuals who do not engage in substance use
behaviors (Brady et al., 1998; Chilcoat & Breslau, 1998; Davis et al., 2009). The self-medicating
relationship between IPT and cannabis use could be mediated by a diagnosis of PTSD and the
high-risk relationship between cannabis use and PTSD could be mediated by IPT. This study
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used these etiologic models of comorbid cannabis use and trauma-related phenotypes to
investigate the mediational relationships between lifetime IPT exposure, probable PTSD, and
new onset cannabis use, as well as lifetime cannabis use, new onset IPT exposure, and probable
PTSD during the first two years of college. Although the overall limitations of this study are
detailed below, two critical limitations relevant to this aim warrant mention prior to
interpretation of the results. First, a major caveat in the interpretation of these results is that the
overall model fit was quite poor, which leads to a lack of confidence in the overall model and
findings. Second, the probable-PTSD assessment is quite poor – consisting of a single item.
Thus, results should be interpreted with caution. Results of these models did not find significant
mediation in support of either self-medication or high-risk hypothesis.
Self-Medication Hypothesis
Path analyses suggest a functional relationship between lifetime IPT exposure and
cannabis use during the first 2 years of college, but that it may not be due to the development of
PTSD. These results are inconsistent with limited previous research, which suggests that
individuals who have experienced IPT and developed PTSD may use cannabis to self-medicate
their distress (Bonn-Miller et al., 2011). Potential reasons for these inconsistent results could be
due to varying ways of measuring cannabis use and PTSD, as well as mechanisms that better
explain self-medicating cannabis use. For example, the dichotomous measure of possible PTSD
used in this study is eliminating the variance that has been shown to exist in other samples
assessing continuous symptoms of PTSD among cannabis users (Bonn-Miller et al., 2011; BonnMiller, Vujanovic, Feldner, Bernstein, & Zvolensky, 2007). Another reason that our hypothesis
may have not been supported could be due to the use of an epidemiological sample versus a
clinical sample. For example, Bonn-Miller and colleagues (2007) used a clinical sample of
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individuals who all reported meeting DSM-IV-TR PTSD Criteria A1 and A2 for at least one
lifetime traumatic event and cannabis use in the past 30 days versus S4S’s sample, which is
representative of the entire VCU student body (Institutional Research and Decision Support,
2018), which is comparable to the national average of young adults regarding overall diversity
(i.e., sex, racial/ethnic distribution) (Pew Research Center, 2010). If previous studies have
documented cannabis use as a self-medicating behavior for PTSD in clinical samples, then it is
possible that a sample consisting of a majority healthy, some subclinical, and even fewer clinical
cases would yield different results. Additionally, Bonn-Miller and colleagues (2011) used a
measure of cannabis use motives in their mediational model in which participants indicated the
degree to which they used cannabis for a variety of possible reasons (e.g., coping). Although
there has been an overall push towards the legalization of medical and recreational cannabis use
in the past decade (Kilmer & MacCoun, 2017), recent research has shown that self-medication of
mood and anxiety disorders with cannabis is higher in states with medical cannabis use laws
compared to those without, such as Virginia (Sarvet et al., 2018). It is worth noting that
medicinal cannabis use was legalized in Vermont in 2004, which could be a confounding factor
influencing Bonn-Miller and colleagues’ (2011; 2007) results. Given the limited number of
studies examining cannabis use and PTSD through a self-medication lens, there is a need for
more longitudinal research on cannabis use as a self-medicating behavior for PTSD in order to
see if the relationship is specific to clinical populations or if it also applies to the general young
adult population.
High-Risk Hypothesis
Path analyses do not suggest a functional relationship between lifetime cannabis use, new
onset IPT exposure, and probable PTSD. Although results did show that more frequent alcohol
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use was associated with subsequent IPT exposure, results specific to cannabis use as the main
substance use behavior are inconsistent with previous substance use (i.e., alcohol, cocaine)
literature that shows individuals who engage in problematic substance use behaviors are more
likely to experience IPT and develop PTSD (Brady et al., 1998; Davis et al., 2009). One of the
few studies that longitudinally examined cannabis use as a risk factor for future IPT exposure
found that cannabis use predicted subsequent sexual victimization and physical assault
victimization (Martino, Collins, & Ellickson, 2004). However, individuals who experienced IPT
following cannabis use were also more likely to be involved in other risky behaviors, such as the
sales of drugs, which could be confounding variables. One of the more recent longitudinal
studies that investigated cannabis use as a risk factor for prospective IPT exposure combined
cannabis use with other substance use (i.e., heroin, opiates, cocaine, alcohol) and found a
positive relationship between substance use and interpersonal violence (Barrett, Teesson, &
Mills, 2014). Potential explanations for the current study’s inconsistent results could be due to
measurement differences. For example, the current study did not separate IPT outcomes into
physical and sexual assault similar to Martino and colleagues (2004) when examining the
relationship between cannabis use, IPT exposure, and PTSD. Likewise, the current study
examined cannabis, alcohol, and nicotine use as separate predictors of IPT exposure and PTSD
unlike Barrett and colleagues (2014). Barrett and colleagues (2014) also used the Clinician
Administered PTSD Scale (CAPS) to measure PTSD symptoms, which is the gold standard for
assessing PTSD (Weathers et al., 2018), opposed to a one-item PTSD screener. Interestingly,
results from this study are more similar to an older study, which found that cannabis users were
at lower risk for developing PTSD compared to other substance users (i.e., cocaine,
hallucinogens, alcohol), but at an increased risk for experiencing trauma exposure similar to
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other substance users (Cottler, Compton, Mager, Spitznagel, & Janca, 1992). Given these
conflicting results, more research is needed to understand individual-level varying factors that
influence the complex relationship between cannabis use, IPT exposure, and the development of
PTSD.
Limitations
Results must be viewed in the context of a number of limitations. First, although college
students are at a high risk for trauma exposure (Elhai et al., 2012; Overstreet et al., 2017; Scarpa
et al., 2002; Vrana & Lauterbach, 1994) and cannabis use (Blavos et al., 2017; Johnston et al.,
2016; Suerken et al., 2014), they are a selected population, which may limit the generalizability
of certain findings. Second, self-reported answers may be subjected to “social desirability” bias
(i.e., people respond in ways that they think will be viewed favorably), which could influence
data collection in the areas of illicit and/or illegal substance use (i.e., cannabis, underage
drinking). Third, the measure used to assess PTSD was a one-item screener tool opposed to a
diagnostic tool used to verify a clinical diagnosis and thus, rates of diagnosed PTSD are not as
accurate as they could be. Using a one-item PTSD screener creates a situation where individuals
who are subclinical and clinical cases are grouped together, which has negative implications in
the data analysis process. For example, if the relationship between IPT exposure and problematic
cannabis use is mediated by PTSD for more severe cases, then a PTSD screener would not be
capable of detecting an effect. A similar limitation also applies to the study’s assessment of IPT
count, where all IPT exposures are weighted equally in terms of how they could lead to increased
risk for negative consequences. However, research shows that some forms of IPT are more likely
to lead to PTSD than others, such as childhood IPT (Hyland et al., 2017), which is not
specifically measured in the current study. Fourth, while scales assessing coping-related motives
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behind using licit substances (i.e., alcohol, nicotine) exist [i.e., Drinking Motives QuestionnaireRevised (Cooper, Russell, Skinner, & Windle, 1992)], no scale exists that measures traumaspecific coping-related cannabis use motives. A more specific scale will likely enrich the
research on cannabis use and its impact on the effects of cannabis in humans, specifically using a
self-medication framework. In order to attain more meaningful results, a standardized assessment
tool for measuring cannabis use should be created, validated, and utilized in future studies.
Currently, assessing cannabis use history can be difficult, especially for recreational cannabis use
due to the lack of a standardized dose, varying levels of THC, and its effect on the body
regarding the multiple routes of administration (Schauer, King, Bunnell, Promoff, & McAfee,
2016). Fifth, assessing whether a specified model fits the data is one of the most important steps
in structural equation modelling (Yuan, 2005). Results from Aim 3 should be interpreted with
caution due to poor model fit. Lastly, while the longitudinal nature of the Spit for Science data is
a strength, the current study used the first, second, and third time points, where the second
timepoint is relatively close to the first (i.e., 6 months). Therefore, there may not be enough time
between assessments for the development of psychopathology to be detected using the brief
assessment tools that were a part of Spit for Science, which could be heavily influencing study
results. Further, only using three of the five time points limits the ability to examine trajectories.
Future research should utilize more than three time points to further investigate these hypotheses
and findings.
Implications and Future Directions
The current study identified both risk factors and consequences of cannabis use and IPT
exposure among college students. Additionally, the current results can serve as a platform for
future longitudinal studies examining the association between trauma-related and cannabis use
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phenotypes to build upon. The cross-sectional and longitudinal association between IPT
exposure and cannabis use remained consistent throughout all aims of the current study, but the
mediational results regarding the self-medication and high-risk hypotheses may not have been
supportive of the hypotheses due to confounding effects of individual-level factors that were not
included in this study (i.e., socioeconomic status, parental income, peer substance use) or this
study’s broad measurement of clinical characteristics (i.e., problematic cannabis use, PTSD) may
not be accurate enough to detect significant effects. However, these findings still have clinical
implications. For example, the association between IPT exposure and subsequent cannabis use
suggests the importance of trying to create safer college environments, particularly in the early
stages of college, in prevention efforts aimed at reducing IPT exposure and cannabis use on
college campuses. Existing work has shown the efficacy of brief interventions (i.e., initiating
bystander intervention programs, safety escorts) aimed at reducing trauma exposure (Coker et
al., 2015; Ponsford, 2016); future work should investigate whether such interventions lead to
decreased cannabis use. Future research should also examine other factors that appear to be
important in the relationship between IPT exposure and cannabis use, such as polysubstance use
(Dierker, Braymiller, Rose, Goodwin, & Selya, 2018; Yurasek, Aston, & Metrik, 2017). Future
investigations into predictors of cannabis use, IPT exposure, and PTSD will assist efforts to
identify, prevent, and treat students at a greater risk for psychopathology. Previous research has
convincingly demonstrated that the more students report using cannabis, the more they skip
classes, have lower GPAs, have enrollment gaps, and do not graduate on time, which are all
relatively short-term consequences of cannabis use that can have negative long-term effects on
life trajectory (Arria et al., 2017; Suerken et al., 2016). Regarding short-term risks, any efforts
made to prevent cannabis use could help improve academic outcomes among college students.
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Given that results of the current study demonstrate that alcohol and nicotine use frequency is
positively associated with cannabis use, the more established health risks of alcohol and nicotine
use (Rehm, 2011; Trofor et al., 2018) could be used as a gateway to build rapport and start the
conversation about potential health risks of cannabis use using a motivational interviewing
approach. The general public currently minimizes potential risks of cannabis use (Keyhani et al.,
2018), so by taking a motivational interviewing approach, individuals may begin to realize that
they may be underestimating potential short- and long-term risks associated with cannabis use.
The gaps in our understanding of the health effects and safety of regular cannabis use are
extensive due to the irregularity of the drug and a lack of longitudinal studies. There is a need for
the continued investment in cannabis use research not only to identify risk and protective factors
for cannabis use, but to better understand short- and long-term consequences and health effects
of cannabis use and how to communicate potential risks to the general public, similar to alcohol
and nicotine use.
Conclusion
Overall, findings support an immediate, small effect of IPT exposure on cannabis use,
which is preliminary evidence for the self-medication hypothesis. Although evidence for the
high-risk hypothesis was not found, both etiologic models of comorbid PTSD-CUD should
continue to be evaluated in other representative samples in order to investigate if and how these
associations form in other populations. Additionally, findings suggest that measurement error
could have an impact on the association between IPT exposure and cannabis use given this
study’s conflicting results with previous studies. The use of more specific assessment tools for
cannabis use as well as PTSD should be used in future studies in order to investigate the
etiologic models of comorbid PTSD-CUD. Although current study results should be interpreted
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with caution due to poor model fit, college mental health centers could screen regularly for
trauma exposure, PTSD, and behaviors such as substance and alcohol use, which could serve as
crucial prevention efforts and treatment targets. This preliminary evidence of an association
between IPT exposure and cannabis use provides an exciting direction for future research, which
is warranted as cannabis use continues to gain public and legislature support for legalization with
little longitudinal research to support how it could potentially affect individuals.

87
References
Agosti, V., Nunes, E., & Levin, F. (2002). Rates of psychiatric comorbidity among U.S.
residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse, 28(4), 643-652.
Agrawal, A., & Lynskey, M. T. (2006). The genetic epidemiology of cannabis use, abuse and
dependence. Addiction, 101(6), 801-812. doi:10.1111/j.1360-0443.2006.01399.x
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders
(DSM-5®). Washington, DC: American Psychiatric Pub.
Anders, S. L., Frazier, P. A., & Shallcross, S. L. (2012). Prevalence and effects of life event
exposure among undergraduate and community college students. J Couns Psychol, 59(3),
449-457. doi:10.1037/a0027753
Anders, S. L., Shallcross, S. L., & Frazier, P. A. (2012). Beyond Criterion A1: the effects of
relational and non-relational traumatic events. J Trauma Dissociation, 13(2), 134-151.
doi:10.1080/15299732.2012.642744
Arria, A. M., Caldeira, K. M., Allen, H. K., Bugbee, B. A., Vincent, K. B., & O'Grady, K. E.
(2017). Prevalence and incidence of drug use among college students: an 8-year
longitudinal analysis. Am J Drug Alcohol Abuse, 43(6), 711-718.
doi:10.1080/00952990.2017.1310219
Barrett, E. L., Teesson, M., & Mills, K. L. (2014). Associations between substance use, posttraumatic stress disorder and the perpetration of violence: A longitudinal investigation.
Addict Behav, 39(6), 1075-1080. doi:10.1016/j.addbeh.2014.03.003
Benjet, C., Bromet, E., Karam, E. G., Kessler, R. C., McLaughlin, K. A., Ruscio, A. M., . . .
Koenen, K. C. (2016). The epidemiology of traumatic event exposure worldwide: results

88
from the World Mental Health Survey Consortium. Psychol Med, 46(2), 327-343.
doi:10.1017/S0033291715001981
Blavos, A. A., Glassman, T. J., Sheu, J. J., Thompson, A., DeNardo, F., & Diehr, A. J. (2017).
Marijuana and college students: A critical review of the literature. American Journal of
Health Education, 48(3), 167-184. doi:10.1080/19325037.2017.1292878
Boden, M. T., Babson, K. A., Vujanovic, A. A., Short, N. A., & Bonn-Miller, M. O. (2013).
Posttraumatic stress disorder and cannabis use characteristics among military veterans
with cannabis dependence. Am J Addict, 22(3), 277-284. doi:10.1111/j.15210391.2012.12018.x
Bohn, M. J., Babor, T. F., & Kranzler, H. R. (1995). The Alcohol Use Disorders Identification
Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud
Alcohol, 56(4), 423-432.
Bohnert, K. M., Ilgen, M. A., Rosen, C. S., Desai, R. A., Austin, K., & Blow, F. C. (2013). The
association between substance use disorders and mortality among a cohort of Veterans
with posttraumatic stress disorder: variation by age cohort and mortality type. Drug
Alcohol Depend, 128(1-2), 98-103. doi:10.1016/j.drugalcdep.2012.08.015
Bonn-Miller, M. O., Harris, A. H., & Trafton, J. A. (2012). Prevalence of cannabis use disorder
diagnoses among veterans in 2002, 2008, and 2009. Psychol Serv, 9(4), 404-416.
doi:10.1037/a0027622
Bonn-Miller, M. O., Vujanovic, A. A., Boden, M. T., & Gross, J. J. (2011). Posttraumatic stress,
difficulties in emotion regulation, and coping-oriented marijuana use. Cogn Behav Ther,
40(1), 34-44. doi:10.1080/16506073.2010.525253

89
Bonn-Miller, M. O., Vujanovic, A. A., Feldner, M. T., Bernstein, A., & Zvolensky, M. J. (2007).
Posttraumatic stress symptom severity predicts marijuana use coping motives among
traumatic event-exposed marijuana users. J Trauma Stress, 20(4), 577-586.
doi:10.1002/jts.20243
Bountress, K. E., Cusack, S. E., Sheerin, C. M., Hawn, S., Dick, D. M., Kendler, K. S., &
Amstadter, A. B. (2019). Alcohol consumption, interpersonal trauma, and drinking to
cope with trauma-related distress: An auto-regressive, cross-lagged model. Psychol
Addict Behav, 33(3), 221-231. doi:10.1037/adb0000457
Bowe, A., & Rosenheck, R. (2015). PTSD and substance use disorder among veterans:
characteristics, service utilization and pharmacotherapy. J Dual Diagn, 11(1), 22-32.
doi:10.1080/15504263.2014.989653
Brady, J. E., & Li, G. (2014). Trends in alcohol and other drugs detected in fatally injured drivers
in the United States, 1999-2010. Am J Epidemiol, 179(6), 692-699.
doi:10.1093/aje/kwt327
Brady, K. T., Dansky, B. S., Sonne, S. C., & Saladin, M. E. (1998). Posttraumatic stress disorder
and cocaine dependence. Order of onset. Am J Addict, 7(2), 128-135.
Bremner, J. D., Southwick, S. M., Darnell, A., & Charney, D. S. (1996). Chronic PTSD in
Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry,
153(3), 369-375. doi:10.1176/ajp.153.3.369
Breslau, N., Davis, G. C., & Schultz, L. R. (2003). Posttraumatic stress disorder and the
incidence of nicotine, alcohol, and other drug disorders in persons who have experienced
trauma. Arch Gen Psychiatry, 60(3), 289-294.

90
Breslau, N., Kessler, R. C., Chilcoat, H. D., Schultz, L. R., Davis, G. C., & Andreski, P. (1998).
Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area
Survey of Trauma. Arch Gen Psychiatry, 55(7), 626-632.
Brewin, C. R., Andrews, B., & Valentine, J. D. (2000). Meta-analysis of risk factors for
posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol, 68(5),
748-766.
Browne, K. C., Dolan, M., Simpson, T. L., Fortney, J. C., & Lehavot, K. (2018). Regular past
year cannabis use in women veterans and associations with sexual trauma. Addict Behav,
84, 144-150. doi:10.1016/j.addbeh.2018.04.007
Bucholz, K. K., Cadoret, R., Cloninger, C. R., Dinwiddie, S. H., Hesselbrock, V. M.,
Nurnberger, J. I., Jr., . . . Schuckit, M. A. (1994). A new, semi-structured psychiatric
interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J
Stud Alcohol, 55(2), 149-158.
Buckner, J. D., Joiner, T. E., Jr., Schmidt, N. B., & Zvolensky, M. J. (2012). Daily marijuana use
and suicidality: the unique impact of social anxiety. Addict Behav, 37(4), 387-392.
doi:10.1016/j.addbeh.2011.11.019
Byrne, B. M. (2013). Structural equation modeling with EQS: Basic concepts, applications, and
programming: Routledge.
Carliner, H., Mauro, P. M., Brown, Q. L., Shmulewitz, D., Rahim-Juwel, R., Sarvet, A. L., . . .
Hasin, D. S. (2017). The widening gender gap in marijuana use prevalence in the U.S.
during a period of economic change, 2002-2014. Drug Alcohol Depend, 170, 51-58.
doi:10.1016/j.drugalcdep.2016.10.042

91
Center for Behavioral Health Statistics and Quality. (2014). National Survey on Drug Use and
Health (NSDUH): Summary of Methodological Studies, 1971–2014. Substance Abuse
and Mental Health Services Administration. Retrieved from Rockville, MD:
https://www.samhsa.gov/data/sites/default/files/NSDUHmethodsSummary2013/NSDUH
methodsSummary2013.pdf
Chilcoat, H. D., & Breslau, N. (1998). Investigations of causal pathways between PTSD and
drug use disorders. Addict Behav, 23(6), 827-840.
Cohen, J., Cohen, P., West, S. G., & Aiken, L. S. (2003). Applied multiple correlation/regression
analysis for the behavioral sciences: Routledge.
Coker, A. L., Fisher, B. S., Bush, H. M., Swan, S. C., Williams, C. M., Clear, E. R., & DeGue, S.
(2015). Evaluation of the Green Dot Bystander Intervention to Reduce Interpersonal
Violence Among College Students Across Three Campuses. Violence Against Women,
21(12), 1507-1527. doi:10.1177/1077801214545284
Compton, M. T., Simmons, C. M., Weiss, P. S., & West, J. C. (2011). Axis IV psychosocial
problems among patients with psychotic or mood disorders with a cannabis use disorder
comorbidity. Am J Addict, 20(6), 563-567. doi:10.1111/j.1521-0391.2011.00184.x
Cook, J., Jakupcak, M., Rosenheck, R., Fontana, A., & McFall, M. (2009). Influence of PTSD
symptom clusters on smoking status among help-seeking Iraq and Afghanistan veterans.
Nicotine Tob Res, 11(10), 1189-1195. doi:10.1093/ntr/ntp123
Cooper, M. L., Russell, M., Skinner, J. B., & Windle, M. (1992). Development and validation of
a three-dimensional measure of drinking motives. Psychological assessment, 4(2), 123.

92
Cornelius, J. R., Kirisci, L., Reynolds, M., Clark, D. B., Hayes, J., & Tarter, R. (2010). PTSD
contributes to teen and young adult cannabis use disorders. Addict Behav, 35(2), 91-94.
doi:10.1016/j.addbeh.2009.09.007
Cottler, L. B., Compton, W. M., 3rd, Mager, D., Spitznagel, E. L., & Janca, A. (1992).
Posttraumatic stress disorder among substance users from the general population. Am J
Psychiatry, 149(5), 664-670. doi:10.1176/ajp.149.5.664
Cougle, J. R., Bonn-Miller, M. O., Vujanovic, A. A., Zvolensky, M. J., & Hawkins, K. A.
(2011). Posttraumatic stress disorder and cannabis use in a nationally representative
sample. Psychol Addict Behav, 25(3), 554-558. doi:10.1037/a0023076
Davis, K. C., Stoner, S. A., Norris, J., George, W. H., & Masters, N. T. (2009). Women's
awareness of and discomfort with sexual assault cues: effects of alcohol consumption and
relationship type. Violence Against Women, 15(9), 1106-1125.
doi:10.1177/1077801209340759
Debell, F., Fear, N. T., Head, M., Batt-Rawden, S., Greenberg, N., Wessely, S., & Goodwin, L.
(2014). A systematic review of the comorbidity between PTSD and alcohol misuse. Soc
Psychiatry Psychiatr Epidemiol, 49(9), 1401-1425. doi:10.1007/s00127-014-0855-7
Dick, D. M., Nasim, A., Edwards, A. C., Salvatore, J. E., Cho, S. B., Adkins, A., . . . Kendler, K.
S. (2014). Spit for Science: launching a longitudinal study of genetic and environmental
influences on substance use and emotional health at a large US university. Front Genet,
5, 47. doi:10.3389/fgene.2014.00047
Dierker, L., Braymiller, J., Rose, J., Goodwin, R., & Selya, A. (2018). Nicotine dependence
predicts cannabis use disorder symptoms among adolescents and young adults. Drug
Alcohol Depend, 187, 212-220. doi:10.1016/j.drugalcdep.2018.02.037

93
Dore, G., Mills, K., Murray, R., Teesson, M., & Farrugia, P. (2012). Post-traumatic stress
disorder, depression and suicidality in inpatients with substance use disorders. Drug
Alcohol Rev, 31(3), 294-302. doi:10.1111/j.1465-3362.2011.00314.x
Dragan, M., & Lis-Turlejska, M. (2007). Prevalence of posttraumatic stress disorder in alcohol
dependent patients in Poland. Addict Behav, 32(5), 902-911.
doi:10.1016/j.addbeh.2006.06.025
Drug Abuse Warning Network. (2011). National Estimates of Drug-Related Emergency
Department Visits: HHS Publication No. (SMA) 13-4760 (Table 9): DAWN Series D-39.
Edwards, E., Bunting, W., & Garcia, L. (2015). The war on marijuana in black and white.
Retrieved from
Edwards, T., Catling, J. C., & Parry, E. (2016). Identifying predictors of resilience in students.
Psychology Teaching Review, 22(1), 26-34.
Elhai, J. D., Miller, M. E., Ford, J. D., Biehn, T. L., Palmieri, P. A., & Frueh, B. C. (2012).
Posttraumatic stress disorder in DSM-5: estimates of prevalence and symptom structure
in a nonclinical sample of college students. J Anxiety Disord, 26(1), 58-64.
doi:10.1016/j.janxdis.2011.08.013
Fedina, L., Holmes, J. L., & Backes, B. L. (2018). Campus Sexual Assault: A Systematic Review
of Prevalence Research From 2000 to 2015. Trauma Violence Abuse, 19(1), 76-93.
doi:10.1177/1524838016631129
Frans, O., Rimmo, P. A., Aberg, L., & Fredrikson, M. (2005). Trauma exposure and posttraumatic stress disorder in the general population. Acta Psychiatr Scand, 111(4), 291299. doi:10.1111/j.1600-0447.2004.00463.x

94
Frazier, P., Anders, S., Perera, S., Tomich, P., Tennen, H., Park, C., & Tashiro, T. (2009).
Traumatic events among undergraduate students: Prevalence and associated symptoms.
Journal of Counseling Psychology, 56(3), 450.
Fu, S. S., McFall, M., Saxon, A. J., Beckham, J. C., Carmody, T. P., Baker, D. G., & Joseph, A.
M. (2007). Post-traumatic stress disorder and smoking: a systematic review. Nicotine Tob
Res, 9(11), 1071-1084. doi:10.1080/14622200701488418
Gabert-Quillen, C. A., Selya, A., & Delahanty, D. L. (2015). Post-traumatic stress disorder
symptoms mediate the relationship between trauma exposure and smoking status in
college students. Stress Health, 31(1), 78-82. doi:10.1002/smi.2543
George, D., & Mallery, P. (2016). IBM SPSS Statistics 23 step by step: A simple guide and
reference: Routledge.
Gielen, N., Havermans, R. C., Tekelenburg, M., & Jansen, A. (2012). Prevalence of posttraumatic stress disorder among patients with substance use disorder: it is higher than
clinicians think it is. Eur J Psychotraumatol, 3. doi:10.3402/ejpt.v3i0.17734
Goodwin, R. D., Pacek, L. R., Copeland, J., Moeller, S. J., Dierker, L., Weinberger, A., . . .
Hasin, D. S. (2018). Trends in Daily Cannabis Use Among Cigarette Smokers: United
States, 2002-2014. Am J Public Health, 108(1), 137-142.
doi:10.2105/AJPH.2017.304050
Grant, B. F., Saha, T. D., Ruan, W. J., Goldstein, R. B., Chou, S. P., Jung, J., . . . Hasin, D. S.
(2016). Epidemiology of DSM-5 Drug Use Disorder: Results From the National
Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry, 73(1),
39-47. doi:10.1001/jamapsychiatry.2015.2132

95
Gray, M. J., Litz, B. T., Hsu, J. L., & Lombardo, T. W. (2004). Psychometric properties of the
life events checklist. Assessment, 11(4), 330-341. doi:10.1177/1073191104269954
Hall, W. D. (1994). The health and psychological effects of cannabis use. Current Issues Crim.
Just., 6, 208.
Hall, W. D. (2006). Cannabis use and the mental health of young people. Aust N Z J Psychiatry,
40(2), 105-113. doi:10.1080/j.1440-1614.2006.01756.x
Hall, W. D., & Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use.
Lancet, 374(9698), 1383-1391. doi:10.1016/S0140-6736(09)61037-0
Hall, W. D., & Pacula, R. L. (2003). Cannabis use and dependence: public health and public
policy: Cambridge university press.
Hapke, U., Schumann, A., Rumpf, H. J., John, U., Konerding, U., & Meyer, C. (2005).
Association of smoking and nicotine dependence with trauma and posttraumatic stress
disorder in a general population sample. J Nerv Ment Dis, 193(12), 843-846.
doi:10.1097/01.nmd.0000188964.83476.e0
Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., . . . Grant, B.
F. (2016). Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013:
Findings from the National Epidemiologic Survey on Alcohol and Related ConditionsIII. Am J Psychiatry, 173(6), 588-599. doi:10.1176/appi.ajp.2015.15070907
Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., . . . Grant, B.
F. (2015). Prevalence of Marijuana Use Disorders in the United States Between 20012002 and 2012-2013. JAMA Psychiatry, 72(12), 1235-1242.
doi:10.1001/jamapsychiatry.2015.1858

96
Hasin, D. S., Sarvet, A. L., Cerda, M., Keyes, K. M., Stohl, M., Galea, S., & Wall, M. M. (2017).
US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws:
1991-1992 to 2012-2013. JAMA Psychiatry, 74(6), 579-588.
doi:10.1001/jamapsychiatry.2017.0724
Heishman, S. J., Arasteh, K., & Stitzer, M. L. (1997). Comparative effects of alcohol and
marijuana on mood, memory, and performance. Pharmacol Biochem Behav, 58(1), 93101. doi:10.1016/s0091-3057(96)00456-x
Heishman, S. J., Stitzer, M. L., & Bigelow, G. E. (1988). Alcohol and marijuana: comparative
dose effect profiles in humans. Pharmacol Biochem Behav, 31(3), 649-655.
doi:10.1016/0091-3057(88)90244-4
Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis:
Conventional criteria versus new alternatives. Structural Equation Modeling: A
Multidisciplinary Journal, 6(1), 1-55.
Hyland, P., Murphy, J., Shevlin, M., Vallieres, F., McElroy, E., Elklit, A., . . . Cloitre, M. (2017).
Variation in post-traumatic response: the role of trauma type in predicting ICD-11 PTSD
and CPTSD symptoms. Soc Psychiatry Psychiatr Epidemiol, 52(6), 727-736.
doi:10.1007/s00127-017-1350-8
IBM Corporation. (2016). SPSS for Mac, version 24.
Institutional Research and Decision Support. (2018). Statistical Summary (2017-18): Enrollment
(Fall 2018). Retrieved from https://opds.vcu.edu/eaar/facts-and-figures/
Jacobsen, L. K., Southwick, S. M., & Kosten, T. R. (2001). Substance use disorders in patients
with posttraumatic stress disorder: a review of the literature. Am J Psychiatry, 158(8),
1184-1190. doi:10.1176/appi.ajp.158.8.1184

97
Jakupcak, M., Tull, M. T., McDermott, M. J., Kaysen, D. L., Hunt, S., & Simpson, T. (2010).
PTSD symptom clusters in relationship to alcohol misuse among Iraq and Afghanistan
war veterans seeking post-deployment VA health care. Addict Behav, 35(9), 840-843.
doi:10.1016/j.addbeh.2010.03.023
Jamal, A., Agaku, I. T., O'Connor, E., King, B. A., Kenemer, J. B., & Neff, L. (2014). Current
cigarette smoking among adults--United States, 2005-2013. MMWR Morb Mortal Wkly
Rep, 63(47), 1108-1112.
Johnson, R. M., Fairman, B., Gilreath, T., Xuan, Z., Rothman, E. F., Parnham, T., & FurrHolden, C. D. (2015). Past 15-year trends in adolescent marijuana use: Differences by
race/ethnicity and sex. Drug Alcohol Depend, 155, 8-15.
doi:10.1016/j.drugalcdep.2015.08.025
Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2006). Monitoring the
future national survey results on drug use 1975–2005. Volume I: Secondary school
students. Retrieved from https://files.eric.ed.gov/fulltext/ED495780.pdf
Johnston, L. D., O’Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Miech, R. A. (2016).
Monitoring the future national survey results on drug use, 1975-2015: Volume II, college
students and adults ages 19-55. Retrieved from
https://deepblue.lib.umich.edu/bitstream/handle/2027.42/137906/mtfvol2_2015.pdf?sequence=1&isAllowed=y
Kalant, H. (2004). Adverse effects of cannabis on health: an update of the literature since 1996.
Prog Neuropsychopharmacol Biol Psychiatry, 28(5), 849-863.
doi:10.1016/j.pnpbp.2004.05.027

98
Kaysen, D., Atkins, D. C., Moore, S. A., Lindgren, K. P., Dillworth, T., & Simpson, T. (2011).
Alcohol Use, Problems, and the Course of Posttraumatic Stress Disorder: A Prospective
Study of Female Crime Victims. J Dual Diagn, 7(4), 262-279.
doi:10.1080/15504263.2011.620449
Kaysen, D. L., Simpson, T., Dillworth, T., Larimer, M. E., Gutner, C., & Resick, P. A. (2006).
Alcohol problems and posttraumatic stress disorder in female crime victims. J Trauma
Stress, 19(3), 399-403. doi:10.1002/jts.20122
Kearns, N. T., Carl, E., Stein, A. T., Vujanovic, A. A., Zvolensky, M. J., Smits, J. A. J., &
Powers, M. B. (2018). Posttraumatic stress disorder and cigarette smoking: A systematic
review. Depress Anxiety, 35(11), 1056-1072. doi:10.1002/da.22828
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999). The assessment of dependence in the
study of stressful life events: validation using a twin design. Psychol Med, 29(6), 14551460.
Kerridge, B. T., Pickering, R., Chou, P., Saha, T. D., & Hasin, D. S. (2018). DSM-5 cannabis use
disorder in the national epidemiologic survey on alcohol and related conditions-III:
gender-specific profiles. Addictive Behaviors, 76, 52-60.
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005).
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National
Comorbidity Survey Replication. Arch Gen Psychiatry, 62(6), 593-602.
doi:10.1001/archpsyc.62.6.593
Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence,
severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity
Survey Replication. Arch Gen Psychiatry, 62(6), 617-627. doi:10.1001/archpsyc.62.6.617

99
Kevorkian, S., Bonn-Miller, M. O., Belendiuk, K., Carney, D. M., Roberson-Nay, R., & Berenz,
E. C. (2015). Associations among trauma, posttraumatic stress disorder, cannabis use,
and cannabis use disorder in a nationally representative epidemiologic sample. Psychol
Addict Behav, 29(3), 633-638. doi:10.1037/adb0000110
Keyes, K. M., Wall, M., Feng, T., Cerda, M., & Hasin, D. S. (2017). Race/ethnicity and
marijuana use in the United States: Diminishing differences in the prevalence of use,
2006-2015. Drug Alcohol Depend, 179, 379-386. doi:10.1016/j.drugalcdep.2017.07.027
Keyhani, S., Steigerwald, S., Ishida, J., Vali, M., Cerda, M., Hasin, D., . . . Cohen, B. E. (2018).
Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults. Ann Intern Med,
169(5), 282-290. doi:10.7326/M18-0810
Khan, S. S., Secades-Villa, R., Okuda, M., Wang, S., Perez-Fuentes, G., Kerridge, B. T., &
Blanco, C. (2013). Gender differences in cannabis use disorders: results from the
National Epidemiologic Survey of Alcohol and Related Conditions. Drug Alcohol
Depend, 130(1-3), 101-108. doi:10.1016/j.drugalcdep.2012.10.015
Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: focus on heroin
and cocaine dependence. Am J Psychiatry, 142(11), 1259-1264.
doi:10.1176/ajp.142.11.1259
Kilmer, B., & MacCoun, R. J. (2017). How medical marijuana smoothed the transition to
marijuana legalization in the United States. Annu. Rev. Law Soc. Sci., 13, 181-202.
doi:10.1146/annurev-lawsocsci-110615-084851
Kilpatrick, D. G., Acierno, R., Saunders, B., Resnick, H. S., Best, C. L., & Schnurr, P. P. (2000).
Risk factors for adolescent substance abuse and dependence: data from a national sample.
J Consult Clin Psychol, 68(1), 19-30.

100
Kilpatrick, D. G., Resnick, H. S., Milanak, M. E., Miller, M. W., Keyes, K. M., & Friedman, M.
J. (2013). National estimates of exposure to traumatic events and PTSD prevalence using
DSM-IV and DSM-5 criteria. J Trauma Stress, 26(5), 537-547. doi:10.1002/jts.21848
Konkoly Thege, B., Horwood, L., Slater, L., Tan, M. C., Hodgins, D. C., & Wild, T. C. (2017).
Relationship between interpersonal trauma exposure and addictive behaviors: a
systematic review. BMC Psychiatry, 17(1), 164. doi:10.1186/s12888-017-1323-1
Krueger, R. F., & Markon, K. E. (2006). Reinterpreting comorbidity: a model-based approach to
understanding and classifying psychopathology. Annu Rev Clin Psychol, 2, 111-133.
doi:10.1146/annurev.clinpsy.2.022305.095213
Leibsohn, J. (1994). The relationship between drug and alcohol use and peer group associations
of college freshmen as they transition from high school. J Drug Educ, 24(3), 177-192.
doi:10.2190/DVYX-PUX7-KA7T-1X4R
Lilly, M. M., & Valdez, C. E. (2012). Interpersonal trauma and PTSD: The roles of gender and a
lifespan perspective in predicting risk. Psychological Trauma: Theory, Research,
Practice, and Policy, 4(1), 140. doi:10.1037/a0022947
Lopez-Quintero, C., Perez de los Cobos, J., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., &
Blanco, C. (2011). Probability and predictors of transition from first use to dependence
on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey
on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend, 115(1-2), 120130. doi:10.1016/j.drugalcdep.2010.11.004
Lyons, M. J., Goldberg, J., Eisen, S. A., True, W., Tsuang, M. T., Meyer, J. M., & Henderson,
W. G. (1993). Do genes influence exposure to trauma? A twin study of combat. Am J
Med Genet, 48(1), 22-27. doi:10.1002/ajmg.1320480107

101
Martino, S. C., Collins, R. L., & Ellickson, P. L. (2004). Substance use and vulnerability to
sexual and physical aggression: a longitudinal study of young adults. Violence Vict,
19(5), 521-540.
Mills, K. L., Lynskey, M., Teesson, M., Ross, J., & Darke, S. (2005). Post-traumatic stress
disorder among people with heroin dependence in the Australian treatment outcome
study (ATOS): prevalence and correlates. Drug Alcohol Depend, 77(3), 243-249.
doi:10.1016/j.drugalcdep.2004.08.016
Muthen, L. K., & Muthen, B. O. (2017). Mplus. Los Angeles: Muthen & Muthen.
Najavits, L. M., & Hien, D. (2013). Helping vulnerable populations: a comprehensive review of
the treatment outcome literature on substance use disorder and PTSD. J Clin Psychol,
69(5), 433-479. doi:10.1002/jclp.21980
National Center for Education Statistics, & US Department of Education. (2016). Fast facts:
Back to school statistics. Retrieved from
https://nces.ed.gov/fastfacts/display.asp?id=372
Neter, J., Wasserman, W., & Kutner, M. G. (1989). Applied linear regression analysis.
Homewood, IL: Irwin.
Netto, L. R., Cavalcanti-Ribeiro, P., Pereira, J. L., Nogueira, J. F., Santos, L. L., Lira, S. B., . . .
Quarantini, L. C. (2013). Clinical and socio-demographic characteristics of college
students exposed to traumatic experiences: a census of seven college institutions in
Northeastern Brazil. PLoS One, 8(11), e78677. doi:10.1371/journal.pone.0078677
North, C. S., Nixon, S. J., Shariat, S., Mallonee, S., McMillen, J. C., Spitznagel, E. L., & Smith,
E. M. (1999). Psychiatric disorders among survivors of the Oklahoma City bombing.
JAMA, 282(8), 755-762.

102
Olff, M. (2017). Sex and gender differences in post-traumatic stress disorder: an update.
European Journal of Psychotraumatology, 8((sup4)), 1351204.
Ouimette, P., Read, J. P., Wade, M., & Tirone, V. (2010). Modeling associations between
posttraumatic stress symptoms and substance use. Addict Behav, 35(1), 64-67.
doi:10.1016/j.addbeh.2009.08.009
Overstreet, C., Berenz, E. C., Kendler, K. S., Dick, D. M., & Amstadter, A. B. (2017). Predictors
and mental health outcomes of potentially traumatic event exposure. Psychiatry Res, 247,
296-304. doi:10.1016/j.psychres.2016.10.047
Ozer, E. J., Best, S. R., Lipsey, T. L., & Weiss, D. S. (2003). Predictors of posttraumatic stress
disorder and symptoms in adults: a meta-analysis. Psychol Bull, 129(1), 52-73.
Pacek, L. R., Malcolm, R. J., & Martins, S. S. (2012). Race/ethnicity differences between
alcohol, marijuana, and co-occurring alcohol and marijuana use disorders and their
association with public health and social problems using a national sample. Am J Addict,
21(5), 435-444. doi:10.1111/j.1521-0391.2012.00249.x
Peirce, J. M., Kindbom, K. A., Waesche, M. C., Yuscavage, A. S., & Brooner, R. K. (2008).
Posttraumatic stress disorder, gender, and problem profiles in substance dependent
patients. Subst Use Misuse, 43(5), 596-611. doi:10.1080/10826080701204623
Pericot-Valverde, I., Elliott, R. J., Miller, M. E., Tidey, J. W., & Gaalema, D. E. (2018).
Posttraumatic stress disorder and tobacco use: A systematic review and meta-analysis.
Addict Behav, 84, 238-247. doi:10.1016/j.addbeh.2018.04.024
Pew Research Center. (2010). Millennials: A Portrait of Generation Next. Retrieved from
https://www.pewresearch.org/wp-content/uploads/sites/3/2010/10/millennials-confidentconnected-open-to-change.pdf

103
Pietrzak, R. H., Goldstein, R. B., Southwick, S. M., & Grant, B. F. (2011). Prevalence and Axis I
comorbidity of full and partial posttraumatic stress disorder in the United States: results
from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.
J Anxiety Disord, 25(3), 456-465. doi:10.1016/j.janxdis.2010.11.010
Ponsford, L. R. (2016). Assessing mental health and violence on college campuses using the
vulnerability model. J Am Assoc Nurse Pract, 28(4), 212-217. doi:10.1002/23276924.12351
Possemato, K., Wade, M., Andersen, J., & Ouimette, P. (2010). The impact of PTSD, depression,
and substance use disorders on disease burden and health care utilization among
OEF/OIF veterans. Psychological Trauma: Theory, Research, Practice, and Policy, 2(3),
218.
Prins, A., Bovin, M. J., Smolenski, D. J., Marx, B. P., Kimerling, R., Jenkins-Guarnieri, M. A., .
. . Tiet, Q. Q. (2016). The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5):
Development and Evaluation Within a Veteran Primary Care Sample. J Gen Intern Med,
31(10), 1206-1211. doi:10.1007/s11606-016-3703-5
Ramaekers, J. G., Berghaus, G., van Laar, M., & Drummer, O. H. (2004). Dose related risk of
motor vehicle crashes after cannabis use. Drug Alcohol Depend, 73(2), 109-119.
Read, J. P., Griffin, M. J., Wardell, J. D., & Ouimette, P. (2014). Coping, PTSD symptoms, and
alcohol involvement in trauma-exposed college students in the first three years of college.
Psychol Addict Behav, 28(4), 1052-1064. doi:10.1037/a0038348
Read, J. P., Ouimette, P., White, J., Colder, C., & Farrow, S. (2011). Rates of DSM-IV-TR
Trauma Exposure and Posttraumatic Stress Disorder Among Newly Matriculated College
Students. Psychol Trauma, 3(2), 148-156. doi:10.1037/a0021260

104
Reed, P. L., Anthony, J. C., & Breslau, N. (2007). Incidence of drug problems in young adults
exposed to trauma and posttraumatic stress disorder: do early life experiences and
predispositions matter? Arch Gen Psychiatry, 64(12), 1435-1442.
doi:10.1001/archpsyc.64.12.1435
Rehm, J. (2011). The risks associated with alcohol use and alcoholism. Alcohol Res Health,
34(2), 135-143.
Reynolds, M., Hinchliffe, K., Asamoah, V., & Kouimtsidis, C. (2011). Trauma and posttraumatic stress disorder in a drug treatment community service. The Psychiatrist, 35(7),
256-260.
Roberts, A. L., Gilman, S. E., Breslau, J., Breslau, N., & Koenen, K. C. (2011). Race/ethnic
differences in exposure to traumatic events, development of post-traumatic stress
disorder, and treatment-seeking for post-traumatic stress disorder in the United States.
Psychol Med, 41(1), 71-83. doi:10.1017/S0033291710000401
Roche, D. J. O., Bujarski, S., Green, R., Hartwell, E. E., Leventhal, A. M., & Ray, L. A. (2019).
Alcohol, tobacco, and marijuana consumption is associated with increased odds of sameday substance co- and tri-use. Drug Alcohol Depend, 200, 40-49.
doi:10.1016/j.drugalcdep.2019.02.035
Rouse, B., Sanderson, C., & Feldmann, J. (2002). Results from the 2001 national household
survey on drug abuse: Volume I. Summary of national findings. Rockville: Substance
Abuse and Mental Health Services Administration, Office of Applied Studies.
Santiago, P. N., Ursano, R. J., Gray, C. L., Pynoos, R. S., Spiegel, D., Lewis-Fernandez, R., . . .
Fullerton, C. S. (2013). A systematic review of PTSD prevalence and trajectories in

105
DSM-5 defined trauma exposed populations: intentional and non-intentional traumatic
events. PLoS One, 8(4), e59236. doi:10.1371/journal.pone.0059236
Sartor, C. E., McCutcheon, V. V., Pommer, N. E., Nelson, E. C., Grant, J. D., Duncan, A. E., . . .
Heath, A. C. (2011). Common genetic and environmental contributions to post-traumatic
stress disorder and alcohol dependence in young women. Psychol Med, 41(7), 14971505. doi:10.1017/S0033291710002072
Sarvet, A. L., Wall, M. M., Keyes, K. M., Olfson, M., Cerda, M., & Hasin, D. S. (2018). Selfmedication of mood and anxiety disorders with marijuana: Higher in states with medical
marijuana laws. Drug Alcohol Depend, 186, 10-15.
doi:10.1016/j.drugalcdep.2018.01.009
Scarpa, A., Fikretoglu, D., Bowser, F., Hurley, J. D., Pappert, C. A., Romero, N., & Van
Voorhees, E. (2002). Community violence exposure in university students: A replication
and extension. Journal of Interpersonal Violence, 17(3), 253-272.
Schauer, G. L., King, B. A., Bunnell, R. E., Promoff, G., & McAfee, T. A. (2016). Toking,
Vaping, and Eating for Health or Fun: Marijuana Use Patterns in Adults, U.S., 2014. Am
J Prev Med, 50(1), 1-8. doi:10.1016/j.amepre.2015.05.027
Shishko, I., Oliveira, R., Moore, T. A., & Almeida, K. (2018). A review of medical marijuana for
the treatment of posttraumatic stress disorder: Real symptom re-leaf or just high hopes?
Mental Health Clinician, 8(2), 86-94.
Smyth, J. M., Hockemeyer, J. R., Heron, K. E., Wonderlich, S. A., & Pennebaker, J. W. (2008).
Prevalence, type, disclosure, and severity of adverse life events in college students. J Am
Coll Health, 57(1), 69-76. doi:10.3200/JACH.57.1.69-76

106
Stein, M. B., Jang, K. L., Taylor, S., Vernon, P. A., & Livesley, W. J. (2002). Genetic and
environmental influences on trauma exposure and posttraumatic stress disorder
symptoms: a twin study. Am J Psychiatry, 159(10), 1675-1681.
doi:10.1176/appi.ajp.159.10.1675
Stekhoven, D. J., & Buhlmann, P. (2012). MissForest--non-parametric missing value imputation
for mixed-type data. Bioinformatics, 28(1), 112-118. doi:10.1093/bioinformatics/btr597
Stewart, S. H., Pihl, R. O., Conrod, P. J., & Dongier, M. (1998). Functional associations among
trauma, PTSD, and substance-related disorders. Addict Behav, 23(6), 797-812.
Stinson, F. S., Ruan, W. J., Pickering, R., & Grant, B. F. (2006). Cannabis use disorders in the
USA: prevalence, correlates and co-morbidity. Psychol Med, 36(10), 1447-1460.
doi:10.1017/S0033291706008361
Substance Abuse and Mental Health Service Administration. (2013). Results from the 2013
National Survey on Drug Use and Health: Summary of National Findings. Retrieved
from Rockville, MD:
https://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/
NSDUHresults2013.pdf
Substance Abuse and Mental Health Services Administration. (2016). Key substance use and
mental health indicators in the United States: Results from the 2015 National Survey on
Drug Use and Health. Substance Abuse and Mental Health Services Administration
website. https://www. samhsa.gov/data/sites/default/files/NSDUH-FFR1-2015/NSDUHFFR1-2015/NSDUH-FFR1-2015.pdf.

107
Suerken, C. K., Reboussin, B. A., Egan, K. L., Sutfin, E. L., Wagoner, K. G., Spangler, J., &
Wolfson, M. (2016). Marijuana use trajectories and academic outcomes among college
students. Drug Alcohol Depend, 162, 137-145. doi:10.1016/j.drugalcdep.2016.02.041
Suerken, C. K., Reboussin, B. A., Sutfin, E. L., Wagoner, K. G., Spangler, J., & Wolfson, M.
(2014). Prevalence of marijuana use at college entry and risk factors for initiation during
freshman year. Addict Behav, 39(1), 302-307.
Sullivan, G. M., & Feinn, R. (2012). Using Effect Size-or Why the P Value Is Not Enough. J
Grad Med Educ, 4(3), 279-282. doi:10.4300/JGME-D-12-00156.1
Swift, W., Coffey, C., Carlin, J. B., Degenhardt, L., & Patton, G. C. (2008). Adolescent cannabis
users at 24 years: trajectories to regular weekly use and dependence in young adulthood.
Addiction, 103(8), 1361-1370. doi:10.1111/j.1360-0443.2008.02246.x
Trofor, A. C., Papadakis, S., Lotrean, L. M., Radu-Loghin, C., Eremia, M., Mihaltan, F., . . .
consortium, E.-P. (2018). Knowledge of the health risks of smoking and impact of
cigarette warning labels among tobacco users in six European countries: Findings from
the EUREST-PLUS ITC Europe Surveys. Tob Induc Dis, 16, A10.
doi:10.18332/tid/99542
Vlahov, D., Galea, S., Resnick, H., Ahern, J., Boscarino, J. A., Bucuvalas, M., . . . Kilpatrick, D.
(2002). Increased use of cigarettes, alcohol, and marijuana among Manhattan, New York,
residents after the September 11th terrorist attacks. Am J Epidemiol, 155(11), 988-996.
Vrana, S., & Lauterbach, D. (1994). Prevalence of traumatic events and post-traumatic
psychological symptoms in a nonclinical sample of college students. J Trauma Stress,
7(2), 289-302.

108
Walsh, A. (1992). Drug use and sexual behavior: users, experimenters, and abstainers. J Soc
Psychol, 132(5), 691-693. doi:10.1080/00224545.1992.9713911
Warner, T. D. (2016). Up in Smoke: Neighborhood Contexts of Marijuana Use from
Adolescence Through Young Adulthood. J Youth Adolesc, 45(1), 35-53.
doi:10.1007/s10964-015-0370-5
Watson, S. B., & Haynes, S. N. (2007). Brief screening for traumatic life events in female
university health service patients. International Journal of Clinical and Health
Psychology, 7(2).
Weathers, F. W., Bovin, M. J., Lee, D. J., Sloan, D. M., Schnurr, P. P., Kaloupek, D. G., . . .
Marx, B. P. (2018). The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5):
Development and initial psychometric evaluation in military veterans. Psychol Assess,
30(3), 383-395. doi:10.1037/pas0000486
Werner, K. B., McCutcheon, V. V., Agrawal, A., Sartor, C. E., Nelson, E. C., Heath, A. C., &
Bucholz, K. K. (2016). The association of specific traumatic experiences with cannabis
initiation and transition to problem use: Differences between African-American and
European-American women. Drug Alcohol Depend, 162, 162-169.
doi:10.1016/j.drugalcdep.2016.03.003
White, H. R., Labouvie, E. W., & Papadaratsakis, V. (2005). Changes in substance use during
the transition to adulthood a comparison of college students and their noncollege age
peers. Journal of Drug Issues, 35(2), 281-305.
Whitehill, J. M., Rivara, F. P., & Moreno, M. A. (2014). Marijuana-using drivers, alcohol-using
drivers, and their passengers: prevalence and risk factors among underage college
students. JAMA Pediatr, 168(7), 618-624. doi:10.1001/jamapediatrics.2013.5300

109
Windle, M. (1994). Substance use, risky behaviors, and victimization among a US national
adolescent sample. Addiction, 89(2), 175-182.
Windle, M., Haardorfer, R., Lloyd, S. A., Foster, B., & Berg, C. J. (2017). Social Influences on
College Student Use of Tobacco Products, Alcohol, and Marijuana. Subst Use Misuse,
52(9), 1111-1119. doi:10.1080/10826084.2017.1290116
Windle, M., & Zucker, R. A. (2010). Reducing underage and young adult drinking: how to
address critical drinking problems during this developmental period. Alcohol Res Health,
33(1-2), 29-44.
Wolf, E. J., Miller, M. W., Krueger, R. F., Lyons, M. J., Tsuang, M. T., & Koenen, K. C. (2010).
Posttraumatic stress disorder and the genetic structure of comorbidity. J Abnorm Psychol,
119(2), 320-330. doi:10.1037/a0019035
Xian, H., Chantarujikapong, S. I., Scherrer, J. F., Eisen, S. A., Lyons, M. J., Goldberg, J., . . .
True, W. R. (2000). Genetic and environmental influences on posttraumatic stress
disorder, alcohol and drug dependence in twin pairs. Drug Alcohol Depend, 61(1), 95102.
Ystrom, E., Reichborn-Kjennerud, T., Neale, M. C., & Kendler, K. S. (2014). Genetic and
environmental risk factors for illicit substance use and use disorders: Joint analysis of self
and co-twin ratings. Behav Genet, 44(1), 1-13. doi:10.1007/s10519-013-9626-6
Yuan, K. H. (2005). Fit Indices Versus Test Statistics. Multivariate Behav Res, 40(1), 115-148.
doi:10.1207/s15327906mbr4001_5
Yurasek, A. M., Aston, E. R., & Metrik, J. (2017). Co-use of alcohol and cannabis: A review.
Current Addiction Reports, 4(2), 184-193.

110
Appendix
Below are the variable names and their corresponding questions from VCU's Spit for Science
student survey:
Alcohol use frequency:

Cannabis use threshold:

Nicotine use frequency:

Sex:
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Race:

Interpersonal trauma:

Probable PTSD:

